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Abstract
In healthy children and adolescents, increased white matter integrity is highly correlated 
with cognitive and language development. Moreover, higher level of physical activity has been 
shown to confer positive effects on cognition and is associated with increased white matter 
microstructure in children. Decreased white matter integrity and impaired cognitive efficiency 
(i.e., speed of information processing) are consistently observed in pediatric-onset multiple 
sclerosis (MS) compared to healthy controls. However, the association between physical activity, 
white matter integrity, and cognition has yet to be fully described in this population. To address 
this gap in the literature, this study aimed to determine whether level of self-reported strenuous 
physical activity is associated with white matter integrity and cognitive efficiency in pediatric-
onset MS patients. We examined white matter integrity in 24 pediatric-onset MS patients and 34 
age- and sex-matched healthy controls via diffusion tensor imaging (DTI) using tract-based 
spatial statistics (TBSS). Participants also completed a neuropsychological test battery (from 
which a cognitive efficiency composite score was derived), and a questionnaire examining self-
reported strenuous physical activity. Findings demonstrated that patients had significantly lower 
white matter integrity relative to healthy controls in the entire white matter skeleton (i.e., across 
the whole brain) and in 21 of 26 interrogated white matter tracts. Cognitive outcomes did not 
associate with indices of white matter integrity. Self-reported strenuous physical activity also did 
not associate with white matter integrity; however, it was positively associated with white matter 
volume in healthy controls, and trended towards a positive association in patients. The results of 
this study confirm that DTI parameters are sensitive to disease pathology in pediatric-onset MS. 
While we did not confirm that white matter integrity was associated with cognitive efficiency, 
this cohort of patients was relatively cognitively preserved, likely masking any relation. No 
association with self-reported strenuous physical activity was noted; however further 
investigation of the positive effects of physical activity on white matter in pediatric-onset MS is 
warranted, as its role in moderating cognitive functioning in this population remains to be 
elucidated.   
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1.0 Introduction and Background 
1.1 Overview of Multiple Sclerosis  
1.1.1 Diagnosis and Causes  
Multiple Sclerosis (MS) is a chronic autoimmune disorder of the central nervous system 
(CNS) that results in neurodegeneration in the brain and spinal cord (Compston & Coles, 2008). 
More specifically, MS manifests as an autoimmune attack against neurons of the CNS, and is 
characterized by focal and diffuse lesions (i.e., tissue damage), resulting in demyelination of 
these cells (Compston & Coles, 2008). Myelin forms an insulating sheath around the axon of the 
neuron, and helps prevent electric current from leaving the axon (Hartline, 2008). As such, 
myelin is responsible for increasing the rate at which neural impulses propagate along the axon, 
resulting in faster and more efficient signals (Hartline, 2008). Damage to myelinated axons (i.e. 
white matter) results in disrupted neuronal transmission. Recent studies have noted, however, 
that MS is no longer characterized solely as a disease affecting white matter, but is also one that 
affects CNS grey matter (i.e. the cell bodies and dendrites of the neuron, from which neural 
impulses originate; Geurts & Barkhof, 2008); grey matter atrophy may be due to the 
inflammatory response of the disease, or secondary to the effects of unstimulated axons (Chard 
et al., 2002).  
The cause of MS is largely unknown, but may be attributed to a combination of 
geographic location, exposure to infection, and genetics (Marrie, 2004). Interestingly, the 
prevalence of MS appears to vary according to geographic latitude, with nations furthest North 
from the equator (i.e. North America and Northern Europe) reporting higher rates of MS than 
equatorial nations (i.e. Central and South America, and Asia; Koch-Henriksen & Sørensen, 
2010). Some research has postulated that level of Vitamin D (i.e., level of sun exposure) may be 
associated with the geographically-attributed prevalence rates, as adults with low levels of 
Vitamin D (e.g. individuals living further from the equator with less sun exposure) have been 
shown to be more susceptible to MS (Yeh et al., 2009). Other research has hypothesized genetics 
as a contributing factor to the impact of geographic location and MS (Milo & Kahana, 2010). 
Additionally, exposure to infection, particularly Epstein-Barr Virus, has been associated with 
higher MS susceptibility (Yeh et al., 2009). Finally, having a family member with MS 
significantly increases one’s risk of developing the disorder, further supporting a genetic 
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association with MS (Koch-Henriksen & Sørensen, 2010). Although identical twin studies have 
demonstrated genetic susceptibility in MS, with a concordance rate of approximately 25%, 
specific genes implicated in the familial forms of the disease have not been confirmed (Koch-
Henriksen & Sørensen, 2010; Milo & Kahana, 2010), although a recent study identified a genetic 
link to MS in a small cohort of patients (Wang et al., 2016). Taken together, it is evident that a 
variety of both genetic and environmental factors may influence the prevalence and development 
of MS.  
As mentioned, MS manifests as an autoimmune attack affecting myelinated axons, 
resulting in lesions in the brain and spinal cord (Vishwas, Chitnis, Pienaar, Healy, & Grant, 
2010). Consequently, depending on the location of neural damage, this disorder can present in a 
variety of symptoms, from sensory impairment to visual and muscular impairment, as well as 
cognitive decline (Compston & Coles, 2008). Unfortunately, there is no cure for this illness, 
warranting endeavours to establish feasible rehabilitation strategies and treatments for this 
patient population. 
1.1.2 Pediatric-Onset Multiple Sclerosis  
MS is typically a diagnosis given to adults, with disease onset occurring between the ages 
of 20 and 40 years (Chiaravalloti & DeLuca, 2008). However, MS can be diagnosed in children 
and adolescents, and pediatric-onset MS (i.e., with onset under 18 years of age) represents 
approximately 3-4% of all cases of MS world-wide (Yeh et al., 2009). In children, MS presents 
largely as a relapsing-remitting disease (such that, remission of neurological symptoms is 
followed by a relapse, rather than progressive neurological disability; Yeh et al., 2009), with 
some research demonstrating a higher relapse rate in pediatric-onset MS compared to adult MS 
(Banwell, Ghezzi, Bar-Or, Mikaeloff, & Tardieu, 2007; Gorman, Healy, Polgar-Turcsanyi, & 
Chitnis, 2009a). A relapse is unpredictable, and is characterized by the emergence of new 
symptoms and the worsening of existing ones, followed by a period of recovery (Gorman, Healy, 
Polgar-Turcsanyi, & Chitnis, 2009b). Longitudinal research has noted that after a 6-year follow-
up, children with MS continue to demonstrate elevated relapse rates in comparison to adults 
(Chitnis, 2013). In adults, progressive subtypes of MS also exist, with symptoms accumulating 
over time. In primary-progressive MS, symptoms accumulate from disease onset, whereas in the 
secondary-progressive subtype, symptoms accumulate 10-20 years following an initial relapsing 
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disease course (Lublin et al., 2014). In children, however, progressive subtypes are very rare, 
with fewer than 3% of patients with pediatric-onset showing this presentation. 
Along with disease progression, there are also noteworthy differences between adult and 
pediatric-onset MS with regards to brain morphology characteristics, as measured by magnetic 
resonance imaging (MRI). In contrast to adults with similar disease duration, pediatric-onset MS 
patients demonstrate higher lesion volume on T2 images (i.e., a type of MRI scan that is more 
sensitive to MS pathology, given that lesions have a higher water content than normal tissue, 
causing them to appear brighter on T2-weighted images; Bitar et al., 2006)), and greater tissue 
injury (Yeh et al., 2009). However, in spite of their higher lesion accrual, pediatric onset patients 
show slower disability accrual, as measured by the Expanded Disability Status Scale (EDSS; 
Chitnis, 2013). Moreover, the median time to reach severe disability (as indexed by a score of 4 
on the EDSS), is 20 years in pediatric-onset MS, compared to 10 years in adult MS (Renoux et 
al., 2007).  
Previous research has noted sufficient differences between pediatric-onset and adult MS. 
As such, further investigation of the mechanisms and symptoms that manifest in the pediatric 
population has been an aim of current research in this field.  
1.2 Multiple Sclerosis and the Developing Brain 
Given that the brain continues to undergo development well into young adulthood (Lebel 
& Beaulieu, 2011), pediatric-onset MS poses a significant risk to normal brain maturation. In 
contrast to adults with MS, who already have mature and established neural networks, 
inflammation and demyelination resulting from MS occur during the critical time when neural 
networks are developing in children (Portaccio et al., 2010). In typical development, a “critical 
period” identifies a maturational stage when the nervous system is particularly sensitive to 
environmental stimuli that contribute to the development of specific functions (Singleton, 2005). 
For example, the critical period for language acquisition in humans is believed to be before 
puberty (Hurford, 1991). If this period is disrupted (e.g., by a lesion to the brain), it may impact 
the development of these functions, resulting in impairment (such as cognitive impairment). 
Consequently, neurodegeneration may have a dramatic impact on cognitive functioning in 
pediatric-onset MS patients.  
In healthy children and adolescents, increases in white matter integrity (i.e., thickening of 
myelin around the axons of the neurons, increases axon diameter, and better organization of 
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white matter tracts) are observed with age (Barnea-Goraly, 2005). Such increases have been 
observed in prefrontal regions of the brain, as well as the basal ganglia, the thalamus, and 
projections from the corpus callosum; regions that are important for attention, motor functioning, 
relaying sensory information, and cognitive ability, respectively (Barnea-Goraly, 2005). 
Moreover, increases in white matter integrity, particularly in frontal regions of the brain, have 
been observed in longitudinal studies, suggesting altered neural plasticity in different regions of 
the brain as one progresses through childhood and adolescence (Krogsrud et al., 2016). In 
adolescents, increased white matter integrity is highly correlated with cognitive and language 
development (Schmithorst & Yuan, 2010), highlighting the impact of white matter integrity on 
cognition.  Some studies have assessed neural connectivity between children and adults, and 
have noted greater white matter integrity in the frontal lobes of adults (aged 20-31) compared to 
children (aged 8-12), further reinforcing the notion that, well into adulthood, neural development 
continues in regions of the brain responsible for higher-order cognitive processes (Klingberg, 
Vaidya, Gabrieli, Moseley, & Hedehus, 1999).  
Given the continuous maturation of the brain during childhood and adolescence, there has 
been an increase in the application of advanced MRI techniques to better understand the impact 
of pediatric-onset MS on developing neural networks. MRI studies have noted declines in age-
expected brain growth among pediatric-onset MS patients (Aubert-Broche et al., 2014), along 
with whole brain atrophy (Kerbrat et al., 2012). Lower thalamic volumes have also been noted in 
pediatric-onset MS patients, compared to healthy controls (Kerbrat et al., 2012; Mesaros et al., 
2008). A study conducted by Aubert-Broche et al. (2014) noted a loss of thalamic volume with 
disease progression (mean follow-up time: 3.55 years), as well as a failure of age-expected 
thalamic growth; a finding that was even more prominent in patients with higher total brain 
lesion load (as indexed by T2-weighted images). Voxel-based morphometry (VBM) techniques 
have been used to assess damage to normal appearing white matter, whereas diffusion tensor 
imaging (DTI) has been used to identify disruption to white matter microstructure (Blaschek et 
al., 2013; Tillema, Leach, & Pirko, 2012; Vishwas et al., 2013). Through the combination of 
these techniques, decreased white matter integrity is consistently observed in pediatric-onset MS 
patients compared to healthy controls (Akbar et al., 2016; Blaschek et al., 2013). Moreover, 
reduced white matter integrity has been correlated with longer disease duration (Blaschek et al., 
2013), and earlier age of onset (trend, Bethune et al., 2011) in pediatric-onset MS patients, 
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stressing the negative impact that the illness poses on brain development, particularly for 
children diagnosed at a young age. Causes of these changes have been attributed to the direct 
negative effects that the illness has on nerve cells, considering that MS may interfere with 
myelination that typically continues well into adolescence, in addition to causing demyelination 
of mature cells (Blaschek et al., 2013). Indirect effects of the illness, such as delayed or inhibited 
neural maturation, have also been attributed to the observed decrease in white matter integrity 
(Blaschek et al., 2013).  
Based on the aforementioned research, it is clear that MS diagnosed in 
childhood/adolescence has a detrimental impact on regional and global brain growth, with a 
particular impact to the development of white matter tracts. Ultimately, the harmful effects of 
MS on maturing neural networks have the potential to impair many brain functions, particularly 
cognition, as myelination of appropriate brain regions has been associated with the development 
of related cognitive functions (Amato et al., 2010). 
1.3 Cognitive Impairment in Pediatric-Onset MS 
1.3.1 Progression of Cognitive Deficits 
Cognitive impairment occurs in one-third of pediatric onset MS patients, with both the 
prevalence and severity of impairment increasing as the disease progresses (Amato et al., 2010; 
Banwell & Anderson, 2005; MacAllister et al., 2005). Cognitive impairment is one of the most 
debilitating aspects of the disease because of its impact on academic performance and quality of 
life, making prevention or remediation of cognitive dysfunction a critical goal for research in this 
field. Deficits are observed in a number of cognitive domains, including attention, processing 
speed, episodic memory, language, and problem solving (Amato et al., 2009; Banwell & 
Anderson, 2005; Cardoso, Olmo, & Fragoso, 2015; MacAllister et al., 2005).  
In addition, up to 50% of patients with pediatric-onset MS report severe fatigue (as 
measured by the PedsQL Multidimensional Fatigue Scale; MacAllister et al., 2009). Notably, an 
association between both self- and parent-reported fatigue and perceived cognitive difficulties 
has been observed in patients (MacAllister et al., 2009). 
Less longitudinal research has been conducted to examine the long-term impact that 
pediatric-onset MS poses on cognitive functioning. Among the longitudinal studies that have 
been conducted (Amato et al., 2010; Hosseini, Flora, Banwell, & Till, 2014; MacAllister, 
Christodoulou, Milazzo, & Krupp, 2007; Till et al., 2013b), loss in cognitive functioning over 
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time or a failure to acquire age-expected developmental gains have been noted. For instance, 
declines in verbal memory, complex attention, verbal fluency, and receptive language after a 2-
year follow-up of pediatric-onset MS patients have been noted (Amato et al., 2010). 
Additionally, greater cognitive decline over a five year period has been noted in patients with a 
younger age of disease onset on tests of processing speed, working memory, and visual scanning 
(Hosseini et al., 2014). Patients with an earlier age of onset not only demonstrated a loss of 
developmental gain in these cognitive domains, but also a progressive loss of cognitive function, 
highlighting the vulnerability of the immature brain. Similar longitudinal studies examining 
cognitive functioning over a one year period have noted that patients with pediatric-onset MS fail 
to show age-related improvements in cognition when compared to healthy controls (Till et al., 
2013).  
1.3.2 Cognitive Efficiency in Pediatric-Onset MS 
Processing speed is a measure of cognitive efficiency and is defined as the ability to 
perform fundamental cognitive operations in an efficient manner (Kail, 2000). It is marked by 
pronounced age differences until adulthood and has been argued as one of the more meaningful 
ways to conceptualize one’s mental capacity (Kail & Salthouse, 1994). Moreover, processing 
speed has been postulated as a fundamental aspect of cognitive development, as it is consistently 
related to measures of higher-order cognition, such as fluid intelligence and short-term memory 
(Kail & Salthouse, 1994). Measures of processing speed have been consistently incorporated in 
neuropsychological batteries evaluating cognitive functioning in pediatric-onset MS patients, as 
they have been shown to be sensitive to MS-related pathology (Denney, Lynch, Parmenter, & 
Horne, 2004).  
Age-related improvements in processing speed appear to be associated with prefrontal 
cortex (PFC) maturation (Rypma et al., 2006). Specifically, white matter integrity of the PFC is 
considerably higher in older, compared to younger, children (Asato, Terwilliger, Woo, & Luna, 
2010; Bunge, Dudukovic, Thomason, Vaidya, & Gabrieli, 2002; Paus et al., 1999; Rypma et al., 
2006). Moreover, increased frontal connectivity has been noted as a predictor of faster reaction 
times in children, further highlighting the importance of frontal network maturation on cognitive 
efficiency (Rypma et al., 2006). 
Reduced information processing speed is commonly observed and manifests early in the 
disease as a result of diffuse damage to white matter in both pediatric-onset and adult MS 
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(Banwell & Anderson, 2005; Bergendal, Fredrikson, & Almkvist, 2007; DeLuca, Chelune, 
Tulsky, Lengenfelder, & Chiaravalloti, 2004; Denney, Lynch, Parmenter, & Horne, 2004; Yeh et 
al., 2009). Bergendal et al. (2007) conducted an 8-year longitudinal study, and noted that, in 
adults with MS, processing speed was one of the strongest predictors of long-term cognitive 
decline. Additionally, DeLuca et al. (2004) noted that, compared to working memory 
performance, processing speed was the greatest cognitive deficit in adults with MS; it should be 
noted, however, that working memory performance can be exacerbated by processing speed 
difficulties in MS patients (Demaree, DeLuca, Gaudino, & Diamond, 1999). In children with 
MS, deficits on tasks that rely upon efficient information processing have also been noted 
(Banwell & Anderson, 2005). Given that white matter has a well-known role in learning and 
information processing (Fields, 2008), the investigation of the implications that MS has on white 
matter integrity in children and adolescents is warranted.   
1.4 White Matter Integrity in Pediatric-Onset MS 
1.4.1 Measuring White Matter Integrity: Diffusion Tensor Imaging 
Measuring neural network integrity, specifically white matter integrity, is conducted by 
Diffusion Tensor Imaging (DTI); an MRI-based neuroimaging technique that evaluates the 
diffusion of water molecules within axons as an indirect measure of axonal structure (Barnea-
Goraly, 2005). Water diffusion in the white matter of the brain is highly sensitive to the axons’ 
cellular membrane integrity, and as such, is able to detect differences in tissue properties that 
may be related to neuroinflammation (Blaschek et al., 2013). DTI is widely employed to 
investigate the integrity of white matter tracts, which are especially vulnerable to the pathology 
of MS.  
There are three factors that contribute to increased white matter integrity and neural 
conduction. These are: dense axonal packing, large axonal diameters, and high levels of 
myelination (Feldman, Yeatman, Lee, Barde, & Gaman-Bean, 2010). Through DTI, a 
mathematical representation of white matter integrity (as measured via water diffusion along 
neural axons) is produced, and is known as the “diffusion ellipsoid.” The diffusion ellipsoid 
quantifies the magnitude and direction of hindrance to water diffusion by axons, myelin 
membranes, and surrounding tissue structures. Three measures of water diffusion in neural tissue 
are commonly reported: axial diffusivity (AD), radial diffusivity (RD), and fractional anisotropy 
(FA; Feldman et al., 2010). AD represents diffusion that is parallel to the main axis of white 
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matter tracts; high AD is indicative of axonal loss. RD indicates diffusion that is perpendicular to 
the main axis; high RD is indicative of myelin injury. AD and RD can be combined to produce 
mean diffusivity (MD); a measure of the average magnitude of water diffusion. Finally, FA is the 
primary measure of white matter integrity and myelination. It integrates both AD and RD, and 
represents the preferential direction of diffusion. High FA values are indicative of anisotropic 
diffusion, as found in highly organized tissues, and low FA reflect regions of more isotropic 
diffusion, as would be found in cerebrospinal fluid (Feldman et al., 2010). A schematic of the 
DTI-derived diffusion parameters (i.e., FA, AD, RD, and MD) is outlined in Figure 1. 
Figure 1. Schematic of DTI-derived diffusion parameters and how they are calculated. AD 
represents diffusion along the length of the axon; RD is diffusion perpendicular to the length of 
the axon; MD is the magnitude of diffusion regardless of direction (A). The diffusion ellipsoid is 
shown with formula for deriving FA (i.e., indicating the principal direction of diffusion; B). 
Schematic derived with reference to Desouza, Hodaie, & Davis (2014). 
Measuring whole-brain differences in white matter microstructure can be facilitated by 
two analytic strategies: voxel-based morphometry (VBM), or tract-based spatial statistics (TBSS; 
Feldman et al., 2010). In voxel-based morphometry, images are registered to a standard space, 
and whole-brain voxelwise statistics are carried out in terms of a diffusion metric, such as FA 
(Feldman et al., 2010). This technique is limited by the need for spatial normalization and 
smoothing that may distort the brain and decrease anatomical specificity. TBSS aims to resolve 
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this technical variability by aligning the FA images from multiple subjects to create a “mean FA 
skeleton” containing only those voxels that are assumed to be at the centre of the white matter 
tracts (Smith et al., 2006). Statistics are then computed at each voxel to identify regions with 
significant differences between groups.  
1.4.2 White Matter Changes in Pediatric-Onset MS 
Whole brain reduction in FA is consistently noted in pediatric-onset MS patients, 
compared to healthy controls (Akbar et al., 2016; Blaschek et al., 2013; Vishwas et al., 2010b). 
Regionally, loss of white matter integrity is observed in the corpus callosum (a region 
responsible for information-transfer between the cerebral hemispheres), suggesting that it may be 
an area of the brain particularly vulnerable to early-onset MS (Akbar et al., 2016; Blaschek et al., 
2013; Tillema et al., 2012; Vishwas et al., 2010b). Indeed, these findings are in accordance with 
DTI research in adult onset MS, which have noted that the earliest changes in white matter 
appear in the corpus callosum (Raz et al., 2010). Rocca et al. (2014) further noted lower FA in 
posterior regions of the brain, such as the posterior corpus callosum and cingulum, as well as 
parieto-occipital white matter in cognitively-impaired pediatric MS patients. Loss of white 
matter integrity has been noted in other tracts, including the internal capsule (Vishwas et al., 
2013), the posterior thalamic radiation, the corona radiata, and the sagittal stratum (Akbar et al., 
2016). Correlations between diffusion parameters and disease-related variables have been noted 
in pediatric MS patients. For instance, longer disease duration has been associated with 
decreased FA values (Blaschek et al., 2013). Additionally, lower FA and higher AD/RD values 
have been associated with increased T2 lesion and reduced thalamic volumes (Akbar et al., 
2016). Differences in normal appearing white matter are also observed between healthy controls 
and pediatric MS patients, with lower FA values in major white matter tracts such as the corpus 
callosum and superior longitudinal fasciculus (Vishwas et al., 2013). This previous research 
underscores the utility of measuring white matter integrity in pediatric-onset MS.  
1.4.3 White Matter Damage and Cognitive Efficiency in Pediatric-Onset MS 
1.4.3.1 The role of lesions 
T1 and T2 lesion volume have been the main MRI metrics used to quantify disease 
severity in MS (Yeh et al., 2009). However, results show that, in general, the strength of the 
association between lesion volume and neuropsychological performance is weak to moderate, at 
best (Rocca et al., 2015; Till et al., 2012; Till et al., 2013b). This is likely attributed to the 
  10 
heterogeneity in location of lesions in white matter tracts, which is not always consistent with the 
clinical manifestation of the disease (Yeh et al., 2009). As previously noted, many studies have 
examined normally appearing white matter (NAWM) in MS, which is measured via region of 
interest (ROI) DTI analyses, whereby ROIs that do not contain lesions are segmented prior to 
extracting AD, RD, and FA values (Ciccarelli et al., 2003; Filippi et al., 2000). 
1.4.3.2 Damage to normal appearing white matter 
To date, only a few studies have examined the association between white matter integrity 
and cognitive performance in patients with pediatric-onset MS. Using DTI, microstructural white 
matter damage in the corpus callosum, particularly the genu and anterior body, was shown to 
associate strongly with reduced visual-perceptual speed (Bethune et al., 2011) and less efficient 
inhibition of irrelevant visual information on a global-local task (Todorow et al., 2014).  
Factoring out processing speed, a robust association was reported between arithmetic score and 
FA in white matter of the corpus callosum and in right frontal and parietal regions (Till et al., 
2011b), consistent with the important role of white matter pathways underlying mathematical 
competence (Tsang, Dougherty, Deutsch, Wandell, & Ben-Shachar, 2009; van Eimeren et al., 
2010). Regarding white matter in the different hemispheric lobes, FA values were lower in the 
pediatric MS patients as compared to controls in all regions of the brain, except for the frontal 
lobes.  The well-established caudo-rostral pattern of myelination through childhood (Paus et al., 
2001; Klingberg et al., 1999) has been suggested to confer some protection of the late maturing 
frontal lobes from MS-related white matter insult (Bethune et al., 2011). That is, given that 
caudal (i.e., posterior) regions of the brain develop first, they may be more vulnerable to white 
matter injury. Whereas, the rostral (i.e., anterior) regions of the brain, such as the frontal cortex, 
have ongoing myelin maturation, allowing this region greater oppostunity to adapt to MS 
pathophysiology.  
Evidence from other pediatric populations with white matter injury, such as traumatic 
brain injury (TBI), have further established the association between cognitive efficiency and 
white matter integrity. Previous research has noted decreased white matter integrity in pediatric 
TBI (Levin et al., 1997). Callosal damage has been noted at the acute stage of injury, along with 
evidence of long-term atrophy, and is generally related to neurocognitive outcome, including 
processing speed, in children with severe TBI (Verger et al., 2001; Ewing-Cobbs, Hasan, Prasad, 
Kramer, & Bachevalier, 2006). In mild to moderate pediatric TBI, decreased white matter 
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integrity has also been observed and has been correlated to decreased processing speed and 
executive functioning (Wozniak et al., 2007). Specifically, decreased frontal white matter 
integrity has been related to decreased executive functioning. Moreover, recent studies noted the 
predictive utility of DTI to identify patients with increased risk of persistent neuropsychological 
deficits in adult TBI (Miles et al., 2008), such that lower white matter integrity at baseline was 
predictive of impaired performance in planning and organization (i.e., prioritizing tasks 
according to a given situation) at six months post-injury (with trends for an association between 
slower processing speed and lower white matter integrity).  
A larger body of research examining white matter integrity and cognition has been 
conducted in adults with MS. A study conducted by Hulst et al. (2013) was able to distinguish 
between cognitively impaired and cognitively preserved MS patients according to white matter 
integrity (as measured with DTI). They noted lower integrity of white matter as assessed by FA 
and RD in cognitively impaired patients, relative to cognitively preserved patients, in major 
white matter tracts (i.e., the corpus callosum, the superior and longitudinal fasciculus, the 
corticospinal tracts, among others). These data confirm the assumption that cognitively impaired 
MS patients may have more severely damaged white matter tracts.  
Associations between reduced scores in tests of information processing speed and 
diffusion parameters have also been reported in adult MS (Dineen et al., 2009; Van Hecke et al., 
2010; Yu et al., 2012). Notably, Van Hecke et al. (2010) found significant correlations between 
performance on the Paced Auditory Serial Addition Test (PASAT) and FA of the genu of the 
corpus callosum, the superior longitudinal fasciculus, the corona radiata, among other major 
white matter tracts. Additionally, Yu et al. (2012) noted significant correlations between 
performance on the Symbol Digit Modalities Test (SDMT) and widespread reduction in FA 
across multiple white matter tracts, with the most pronounced associations with FA of the 
posterior thalamic radiation, corpus callosum, and fornix.  
In addition to the DTI findings, further research has noted decreased functional 
connectivity in resting-state networks involved in cognition, sensorimotor, and executive 
functions in pediatric-onset MS patients compared to healthy controls (Akbar et al., 2016; Rocca 
et al., 2014a). Other studies have noted neural connectivity differences between cognitively-
impaired and cognitively-preserved pediatric-onset MS patients (Rocca et al., 2014), such that 
cognitively-impaired patients demonstrated decreased functional connectivity of the precuneus 
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(a region involved in visuospatial and episodic memory; Rocca et al., 2014), whereas 
cognitively-preserved patients demonstrated increased functional connectivity of the anterior 
cingulate cortex (a region involved in rational cognitive functions, such as decision-making; 
Bush, Luu, & Posner, 2000). Such findings provide evidence for the functional reorganization of 
neural networks to delay cognitive decline in pediatric-onset MS patients.  Preliminary research 
has established a relation between white matter integrity and cognitive efficiency in both adult 
and pediatric-onset MS. While correlates of this relationship have been studied to a lesser degree 
in the pediatric population, research in adult MS has demonstrated that physical activity may be 
associated with white matter integrity in this population.  
1.5 Physical Activity and Brain Structure and Function 
1.5.1 Benefits of Physical Activity in Healthy Children and Adolescents 
The beneficial effects of physical activity are well-described, and both human and animal 
studies have indicated that exercise is capable of improving learning capacity in both healthy and 
neurological populations, and assisting in restorative processes post-brain injury (Griesbach, 
2011). In healthy adults, higher cardiorespiratory fitness has been associated with greater 
prefrontal gray matter volume (Erickson, Leckie, & Weinstein, 2014); such effects of physical 
activity on the brain have also been observed in children, and have been related to higher 
performance on cognitive measures of working memory, inhibition, and cognitive flexibility 
(Chaddock, Pontifex, Hillman, & Kramer, 2011; Chaddock et al., 2010). Moreover, Chaddock-
Heyman et al. (2014) noted that higher-fit 9 and 10 year-old children demonstrated greater white 
matter microstructure in the corpus callosum, corona radiata, and superior longitudinal 
fasciculus, compared to lower-fit children.  
Several mechanisms through which physical activity is associated with cognitive and 
neurological outcomes have been studied. Brain-derived neurotrophic factor (BDNF; a protein 
implicated in neural survival, growth, and synaptic plasticity; Szuhany, Bugatti, & Otto, 2015) 
has been postulated as one such mechanism. Neeper, Gomez-Pinilla, Choi, & Cotman (1995) 
were the first to show a positive association between physical activity and BDNF mRNA levels 
in the rat brain, following voluntary wheel running. Increased BDNF gene expression has been 
noted following both voluntary and forced animal exercise protocols in the hippocampus, 
cerebellum, amygdala, and caudal neocortex (Voss, Vivar, Kramer, & van Praag, 2013).  
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Indeed, physical activity has been shown to elevate cerebrovascular activity and increase 
the release of BDNF, among other neurotrophic factors, such as nerve growth factor (NGF), 
growth hormone (GH) and neurotrophin-3; proteins that stimulate neurogenesis (Archer, 
Svensson, & Alricsson, 2012). In both healthy and clinical adult populations, studies have noted 
a relation between BDNF and cognitive processes, such as, episodic (Egan et al., 2003), and 
verbal memory (Grassi-Oliveira, Stein, Lopes, Teixeira, & Bauer, 2008).  
Increased vasculature (i.e., angiogenesis), and as a result, increased perfusion of blood to 
the brain, may be another mechanism through which physical activity confers its positive effects 
on cognition (Voss et al., 2013). Following a 3-month training program in adults aged 21 to 45 
years, Pereira et al. (2007) noted increased cerebral blood volume to the dentate gyrus of the 
hippocampus. Chaddock-Heyman et al. (2016) were the first to investigate this effect in children, 
and noted greater blood perfusion in the hippocampus (as measured via arterial spin labelling) in 
higher-fit children (aged 7 to 9) versus lower-fit children. 
Engagement in aerobic activity has been associated with both structural and functional 
brain changes, along with improved cognitive function across the lifespan. Such findings have 
bolstered research examining the therapeutic effects of exercise in clinical populations. 
1.5.2 Evidence from Adult MS Research  
Physical activity has been associated with greater measures of cognitive processing speed 
in adult MS patients (Motl, Gappmaier, Nelson & Benedict, 2011). Briken et al. (2014) 
conducted a randomized controlled trial (RCT) with adult MS patients investigating three 
different exercise intervention techniques (arm ergometry, rowing, and bicycle ergometry). They 
noted improvements in verbal memory and delayed recall after 8-10 weeks of training (2-3 
twenty-minute sessions/week), compared to a waitlist control group.  
Accumulating research conducted in adults with MS has noted that physical activity is 
capable of influencing the structural and functional properties of the brain (Dalgas & Stenager, 
2012; Ibrahim et al., 2011; Prakash, Snook, Motl, & Kramer, 2010). These studies have provided 
evidence for the plasticity of both gray matter regions and white matter fibers in MS, in response 
to physical activity. A study conducted by Prakash et al. (2010) noted that aerobic fitness was 
associated with increased white matter integrity in adults with MS. While this study noted that 
MS patients had decreased processing speed and white matter integrity than healthy controls, 
they observed that higher levels of fitness in patients were associated with higher scores on 
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measures of processing speed, as well as greater integrity of white matter tracts in the thalamus 
and corpus callosum; structures that have been previously associated with cognitive impairment 
in MS (Prakash et al., 2010).  
Another study noted changes in white matter microstructure of adult MS patients after a 
two-month physiotherapy intervention (Ibrahim et al., 2011). This study noted that after patients 
participated in two hours/week of physiotherapy for two months, increases in white matter 
integrity (i.e., increased FA and decreased MD from baseline to post-intervention) was observed 
in the corpus callosum. Furthermore, this study noted improvement in measures of working 
memory, processing speed, and cognitive flexibility post-intervention. Consistent with these 
findings, a randomized controlled trial conducted by Prosperini et al. (2014) noted increases in 
white matter integrity in adults with MS following a 12-week training protocol with a video 
game balance board (Nintendo Wii).  
Together, these studies provide evidence for an association between physical activity, 
cognitive impairment, and white matter integrity in adult MS, and suggest possible neuroplastic 
mechanisms that may be responsible for the positive effects of physical activity. Such 
mechanisms include remyelination of white matter tracts, increases in neural connectivity, or the 
recruitment of new networks to complete a task (Ibrahim et al., 2011). In light of this research, 
exercise is becoming increasingly promoted by healthcare providers for the clinical care and 
management of MS (Motl & Sandroff, 2015). However, much of the research investigating the 
benefits of physical activity in the MS population has been conducted on adult MS patients. A 
gap in the literature exists with respect to defining the relationship between physical activity, 
white matter integrity, and cognitive function in pediatric-onset MS patients.  
1.5.3 Preliminary Evidence in Pediatric Onset MS 
The effect of physical activity on pediatric-onset MS has yet to be fully described, though 
preliminary evidence suggests that exercise confers some benefits for this clinical population. 
Specifically, higher levels of self-reported vigorous physical activity was inversely related to 
fatigue in pediatric-onset MS patients, but not in controls (Yeh, Kinnett-Hopkins, Grover, & 
Motl, 2015). Youth with MS are significantly less likely to be physically active compared to 
youth with monophasic acquired demyelinating syndrome (mono-ADS; Grover et al., 2015). 
Mono-ADS is a monophasic illness characterized by a single demyelinating event in the CNS, in 
contrast to MS, which is characterized by multiple demyelinating events (Verhey et al., 2011) 
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Moreover, accelerometer data has shown that pediatric-onset MS patients participate in fewer 
minutes/day of vigorous physical activity, relative to youth with mono-ADS and healthy controls 
(Grover et al., 2015). This may be a consequence of MS being a more aggressive disease than 
mono-ADS. Associations have been observed between markers of disease severity and physical 
activity, such that increased physical activity was related to smaller T2 lesion volumes and 
decreased relapse rates (Grover et al., 2015); however, a causal effect of physical activity on 
these disease metrics cannot be inferred, as these findings were purely correlational. 
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2.0 Rationale 
Cognitive impairment is a debilitating symptom of MS that occurs in roughly one-third of 
children and adolescents with MS. Currently, there is little known about modifiable factors that 
may contribute to the preservation of neural networks and underlying cognitive processes in 
pediatric-onset MS. Research in adult MS has noted that physical activity may be associated with 
decreased disease pathology, though the extent of this effect has not been studied in pediatric-
onset MS.  Exploring the potential benefits of physical activity in individuals with pediatric-
onset MS is a worthwhile endeavor, as these patients may be especially vulnerable to the 
disruption of white matter pathways and cognitive decline. Moreover, investigating the neural 
mechanisms underlying the benefits of exercise for pediatric-onset MS is important for 
understanding potential protective factors of the disease process. Research is therefore needed to 
identify whether physical activity is associated with white matter integrity and cognition in the 
pediatric-onset MS population.  
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3.0 Objectives and Hypotheses 
Objective: The proposed study aimed to measure the relation between white matter 
integrity, cognitive efficiency, and self-reported, strenuous physical activity in patients with 
pediatric-onset MS. A supplementary aim compared the strength of this relationship across 
patients and healthy controls. 
Hypothesis A: Whole brain white matter integrity was expected to be lower in pediatric-
onset MS patients compared to healthy controls. Lower white matter integrity was also expected 
to be lower in pediatric-onset MS patients in tracts that have been identified as more vulnerable 
to MS pathology (i.e., the corpus callosum and projections from the thalamus).  
Hypothesis B: Cognitive efficiency was expected to be lower in pediatric-onset MS 
patients, compared to healthy controls 
Hypothesis C: Higher reports of strenuous physical activity were expected to be 
associated with higher whole brain white matter integrity and greater cognitive efficiency. This 
association was also expected to be observed in major white matter tracts, including the corpus 
callosum the superior longitudinal fasciculus, and the posterior thalamic radiation (which have 
been observed as particularly vulnerable to MS disease pathology).  
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4.0 Method 
This study was approved by the Research Ethics Board at York University and the 
Hospital for Sick Children. Participants older than 16 years provided informed consent, whereas 
younger participants provided verbal assent; parents of younger participants provided written 
informed consent.  
4.1 Participants  
This study examined previously-collected data from a sample of 25 pediatric-onset 
relapsing remitting MS patients (aged 14-25). Patients were recruited for this study from the 
Pediatric Demyelinating clinic at the Hospital for Sick Children (Toronto, ON). Patients were 
informed of the study by letter, followed by a telephone screen by a research assistant. Thirty-
eight age- and gender-matched healthy controls were recruited from the Undergraduate Research 
Participant Pool (URPP) at York University, and from local advertisements (i.e., flyers).  
All participants recruited for this study were between 13-25 years of age. All patients 
were required to meet the revised McDonald 2010 MS diagnostic criteria (Polman et al., 2011) 
for relapsing-remitting MS, and to be younger than 18 years of age at the time of the first MS 
attack. MS patients were also required to be at least four weeks from clinical relapse or 
corticosteroid treatment. These criteria were implemented, as visual/motor disturbances and MRI 
abnormalities have been noted during cognitive testing and MRI during clinical relapse. 
Moreover, declines in processing speed have been observed in patients experiencing a relapse 
(Benedict et al., 2014).  
The following exclusion criteria were implemented: 1) history of significant head trauma 
(i.e., loss of consciousness for more than 5 minutes and a score of less than 13 on the Glasgow 
Coma Scale); 2) history of alcohol abuse, or illicit drug use (greater than once per week); 3) 
major medical illness that could affect cognitive functioning; 4) visual or motor difficulties that 
would preclude testing; 5) lack of proficiency in English. History of a mood-related disorder 
(e.g., depression) was not exclusionary, as such symptoms may be secondary to the MS disease 
process. Apart from MS diagnosis, age- and sex-matched healthy controls met the same 
inclusion/exclusion criteria; however, controls were not recruited if they reported history of 
neurological illness, psychiatric diagnosis, or known learning disability. To limit practice effects, 
all participants were required to be more than 6 months from any previous neuropsychological 
evaluation.  
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4.2 Study Procedure 
Upon receiving a study information letter, and agreeing to be contacted by the research 
assistant, participants were screened (by telephone, or in clinic) via a screening form to ensure 
that inclusion and exclusion criteria were met. Participants also completed an MRI screening 
form prior to testing, to ensure that they were eligible to enter the scanner.  
Testing occurred at York University and lasted approximately 3 hours, with breaks. The 
testing procedure included questionnaires to collect information regarding demographics, mood, 
and fatigue. Participants then completed a 60-minute neuropsychological test battery. Finally, an 
MRI scan was conducted using a Siemens MAGNETOM 3T Tim Trio MRI scanner at York 
University. Scans lasted approximately 90 minutes for patients, and 70 minutes for controls. All 
participants were reimbursed $20 for parking/public transportation.   
4.3 Measures 
4.3.1 Clinical-Demographic Information  
Clinical information was obtained for patients through chart review or communication 
with their neurologist, on the following outcomes within 3 months of the study: age at disease 
onset (i.e., age at first MS attack), total number of relapses, medication use, and physical 
disability (assessed by a neurologist via the Expanded Disability Status Scale [EDSS]; Kurtzke, 
1983).  
The following information was collected from all participants via questionnaires: 1) 
general health and demographic information (Case History Form; Appendix A); 2) handedness 
(Dutch Handedness Questionnaire; Strien, 1992); 3) mood (Center for Epidemiologic Studies 
Depression Scale [CES-D]; Faulstich, Carey, Ruggiero, Enyart, & Gresham, 1986); 4) three 
dimensions of fatigue – General, Cognitive, and Sleep/Rest (Varni Pediatric Quality of Life 
[PedsQL] Multidimensional Fatigue Scale; Varni, Seid, & Rode, 1999); 5) socioeconomic status, 
as determined by parental education and occupational status (Barratt Simplified Measure of 
Social Status; Barratt, 2005); and 6) physical activity (Godin-Shephard Leisure-Time Exercise 
Questionnaire; Godin, 2011).  
4.3.2 Neuropsychological Battery 
A battery of clinical neuropsychological tests was employed to assess the following 
cognitive domains: general intellectual function (IQ), focused attention and cognitive flexibility, 
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cognitive efficiency/speed of processing, learning and memory, and motor function (patients 
only). A list of the neuropsychological measures is presented in Table 1.  





Wechsler Abbreviated Scales of Intelligence (WASI) – 
two subtest estimate of Full Scale IQ (Wechsler, 1999) 
• Vocabulary: general word knowledge 
• Matrix Reasoning: nonverbal conceptual 
reasoning 
 
FOCUSED ATTENTION AND 
COGNITIVE FLEXIBILITY 
 
Trail Making Test – Parts A and B (Reitan, 1959) 
 
Woodcock Johnson (WJ-III): Auditory Working 
Memory (Schrank, 2010) 
 
SPEED OF PROCESSING  
 
 
Symbol Digits Modalities Test (SDMT) – Oral Version 
(A. Smith, 1968) 
 
WJ-III: Decision speed (Woodcock, McGrew, & 
Mather, 2001) 
 
LEARNING & MEMORY 
 
Rey Auditory Verbal Learning Test (RAVLT; Lezak, 
1983) 
 
MOTOR FUNCTION (PATIENTS) 
 
Nine Hole Peg Test (9-HPT) (norms from Mathiowetz, 
Weber, Kashman, & Volland, 1985) 
 
4.3.2.1 Speed of Processing Measures 
This study focused on the neuropsychological measures that evaluated speed of 
processing. These included the Symbol Digit Modalities Test (SDMT) (oral version), and the 
Woodcock Johnson (WJ-III) Decision Speed subtest. The SDMT requires participants to orally 
match symbols to numbers according to a key within 90 seconds. It measures attention, 
concentration, and speed of processing (Smith, 1991). This task has demonstrated strong test-
retest reliability in a cohort of 85 adult MS patients who were tested monthly for 5 sessions 
(Benedict et al., 2008). It is known to be sensitive in distinguishing MS patients from healthy 
controls, and for detecting cognitive impairment in adult MS patients (Lopez-Gongora et al., 
2015; Parmenter et al., 2007; Schependom et al., 2014). Moreover, scores on the SDMT have 
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been shown to correlate with other measures of neuropsychological performance, such as 
memory and executive function (Lopez-Gongora et al., 2015). In pediatric-onset MS, the SDMT 
score has been sensitive to noting decline in processing speed over time (Till et al., 2013), and 
has been associated with age of disease onset (Till et al., 2012).  Performance on this test is also 
associated with indices of disease burden, including global and regional brain MRI metrics, and 
to a lesser extent, T1- and T2-lesion volumes (Till et al., 2011). Because of its sensitivity to 
detecting cognitive impairment, the SDMT is one of the core tests in the validated Brief 
Neuropsychological Battery for Children (BNBC) (Portaccio et al., 2009). 
To complement the SDMT, a secondary measure of processing speed, the WJ-III 
Decision Speed subtest, was assessed. This task assesses semantic processing speed and requires 
participants to quickly locate two pictures that are most similar conceptually, within a 3-minute 
time limit (Schrank, 2010). It has demonstrated good test-retest reliability (above 0.70) across 
age groups (Schrank & Woodcock, 2001). Although it has not been used extensively in pediatric-
onset MS, it provides complementary information regarding processing speed within the cohort 
involved in this study.  
A cognitive efficiency composite score was generated for each participant by calculating 
the mean of the SDMT and the WJ-III Decision Speed scores.  A neuropsychological composite 
score was estimated for each participant by calculating the mean z-score of seven subtests from 
the test battery (i.e., RAVLT total score, TMT-B, WASI Vocabulary and Matrix Reasoning, 
SDMT, WJ-III Decision Speed and Auditory Working Memory).  
4.3.2.2 Assessment of Physical Activity Level  
The Godin-Shephard Leisure-Time Physical Activity Questionnaire (GLTPAQ) was used 
to assess physical activity level. This questionnaire is a self-report measure that asks subjects to 
recall the amount of times in the last 7 days that they spent more than 15 minutes doing exercise 
that is classified as mild (i.e., requiring minimal effort), moderate (i.e., not exhausting), or 
strenuous (i.e., causing the heart to beat rapidly). For each classification, examples of exercises 
are provided. From these weekly frequencies, a “weekly leisurely activity”, or leisure index score 
can be derived. The questionnaire also queries the number of times per week that one engages in 
physical activity long enough to work up a sweat.  
The GLTPAQ has shown good reliability and validity in previous studies (Jacobs, 
Ainsworth, Hartman, & Leon, 1993; Sallis, Buono, Roby, Micale, & Nelson, 1993). High test-
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retest reliability has been noted for the leisure index score (r=0.74, Godin & Shephard, 1985; 
0.81, Sallis et al., 1993) over a 2-week testing period. Godin & Shephard (1985) further noted 
high test-retest reliability for the measure of self-reported strenuous exercise (0.94), with lower 
reliability for self-reported mild and moderate exercise (r=0.48 and 0.46, respectively). A similar 
study was conducted with adults aged 20-59 (Jacobs et al., 1993). Over a one-month interval, 
they noted high test-retest reliability of the leisure index (r=0.62) and self-reported strenuous 
exercise (r=0.84). Lower test-retest reliability was noted for self-reported mild or moderate 
exercise (r=0.24 and 0.36, respectively). This study also found that the leisure index was 
positively associated with motion score as assessed using an accelerometer (metabolic equivalent 
in min/day), and maximum oxygen consumption (VO2max). Moreover, the leisure index was 
negatively correlated with total body fat. Godin & Shephard (1985) also observed that the 
measure of strenuous exercise was moderately correlated to VO2max (r=0.38).  
As mentioned previously, the GLTPAQ has been used to evaluate the association 
between physical activity and disease activity in pediatric-onset MS and monophasic 
demyelinating syndrome (mono-ADS) patients (Grover et al., 2015). MS patients reported 
participating in less strenuous physical activity compared to mono-ADS patients; groups did not 
differ in moderate or mild PA. Another study by the same group observed correlations between 
accelerometry data and the GLTPAQ measure in children with demyelination (Grover et al., 
2015).  
Based on this previous work, this study examined self-reported strenuous exercise and as 
the measure of interest for estimating physical activity among participants.   
4.3.4 MRI Protocol  
All data were acquired on a Siemens MAGNETOM 3T Tim Trio MRI scanner at York 
University with a 32-channel head coil. The 90-minute scanning protocol included the following: 
T1-weighted sagittal MPRAGE, resting state functional MRI (fMRI), three task-based fMRI 
paradigms, DTI, proton-density (PD), T2-weighted, and FLAIR sequences. The T1-weighted 
three-dimensional MPRAGE sequence [1 mm isotropic voxel size, TR=2300 ms, TE=2.96 ms, 
field of view (FOV) = 256x240x192mm, number of slides =192] was used to measure brain 
volume, register images, and perform anatomical mapping.  DTI images were recorded using a 
2D echo-planar imaging (EPI) sequence with diffusion weighting in 64 directions and b-value of 
1000s/mm2 (TR=4600 ms, TE=93ms, FOV=256x256x108mm, number of slices=36, voxel 
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size=2.0x2.0x3.0mm). The PD,  (TR=2200 ms, TE=10 ms, turbo factor=4) and T2-weighted 
(TR=4500 ms, TE=83 ms, turbo factor=11) images were acquired for lesion segmentation using 
2D turbo spin-echo sequences with 1x1x3 mm3 voxel size, along with a matching 2D turbo 
FLAIR sequence with TR=9000 ms, TE=88 ms, TI=2407.5 ms.  The resting state and task-based 
fMRI data were collected as part of other studies conducted in the same population (Akbar et al. 
2015; 2016). 
3.3.4.1 Lesion Segmentation  
Image processing and structural MRI analyses were performed at the Montreal 
Neurological Institute (MNI; Montreal, QC) by trained staff who were blinded to clinical and 
behavioural data.  
A preprocessing routine was run on all images to correct for intensity non-uniformity 
(Sled, Zijdenbos, & Evans, 1998), to remove skull and scalp (Smith, 2002), and to linearly 
register the T1-weighted images to the PD- and T2-weighted image to provide voxel-wise 
anatomical alignment across the modalities (Collins, Neelin, Peters, & Evans, 1994). Second, the 
intensity range was normalized within each image, using a two-piece linear transformation as 
described in Nyul and Udupa (1999). Third, using an interactive, mouse-driven visualization 
software package (DISPLAY, McConnell Brain Imaging Centre, Montreal Neurological 
Institute), the T2-weighted lesion labels output by an initial automated segmentation procedure 
were superimposed on the T1-, T2-, and PD-weighted images, carefully reviewed and, if 
necessary, manually corrected. Given their different MRI intensity characteristics, infratentorial 
T2-weighted lesions were segmented manually. Hypointense regions on T1-weighted images 
(T1-weighted lesions) located within the T2-weighted lesions were automatically segmented by 
applying an intensity threshold of 85% relative to the mean intensity of surrounding normal-
appearing WM. Supratentorial and infratentorial lesion volumes were combined as a measure of 
total brain lesion volume.  
4.3.4.2 Brain and Thalamus Segmentation 
Three standard preprocessing steps were applied to the native T1-weighted images to 
delineate the thalamus. These included: (1) removing noise by using the optimized non-local 
means filter (Coupe, Hellier, Prima, Kervrann, & Barillot, 2008); (2) reducing the impact of 
intensity inhomogeneity due to RF coil variations using a non-parametric estimation of the slow 
varying non-uniformity field (Sled et al., 1998), and (3) normalizing the brain volume intensities 
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to the intensities of the target template [i.e., the ICBM152 population template (Fonov et al., 
2011)] by doing regression based analyses on image intensity percentiles.  
The following steps were then conducted on the preprocessed images: (1) a mixture of 
linear and non-linear transformation (Collins et al., 1994) of the raw T1-weighted image to 
ICBM152 population template space (Fonov et al., 2011), (2) brain extraction using a library of 
tissue priors that are available in the ICBM152 population template (Eskildsen et al., 2012), (3) 
warping of the thalamus onto the raw T1-weighted image using the inverse of the transformation 
generated in step (1). Thalamic volumes were normalized for head size by dividing by total 
intracranial volume.  
Normalized whole-brain GM and WM volumes were estimated using SIENAX (Smith 
2001, Smith 2002b). First, the brain and skull were extracted from the T1 image (Smith 2002). 
The brain image was then affine-registered to Montreal Neurological Institute (MNI)152 space, 
using the skull image to determine the registration scaling (Jenkinson 2001, Jenkinson 2002). 
Subsequently, tissue-type segmentation with partial volume estimation was carried out (Zhang 
2001) in order to calculate total volume of brain tissue.  
4.4 Analyses 
4.4.1 DTI Processing 
DTI processing was conducted at York University using FMRIB Software Library (FSL; 
www.fmrib.ox.ac.uk/fsl/). DTI images were examined for quality control in fslview prior to 
preprocessing, and slices which demonstrated noise artifacts were removed (one slice was 
removed in two participant scans).  
The preprocessing protocol was as follows; first, DTI data were corrected for MRI eddy 
currents and head motion using affine registration to a reference volume (i.e., where b=0). Brain 
masks were generated using the Brain Extraction Tool (BET) and entered into the DTIFIT 
program, which creates a diffusion tensor model at each voxel. As a result of preprocessing, 
images representing fractional anisotropy (FA), axial diffusivity (AD), and radial diffusivity 
(RD) were created for each subject on a voxel-wise level.  
In order to conduct voxel-wise between-group comparisons of the DTI data, Tract-Based 
Spatial Statistics (TBSS) was employed (Smith et al., 2006). As mentioned previously, in TBSS, 
the whole brain is investigated, and prespecification of tracts of interest is not required. This 
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method estimates a “group mean FA skeleton” representing the centres of all of the fibre bundles 
of the subjects included in the analysis.   
Individual FA images were aligned to a 1x1x1mm3 standard space, via nonlinear 
registration. This was followed by the creation of a mean FA image that was used to create the 
mean FA white matter skeleton (set at a threshold of 0.2). The white matter skeleton includes 
only the voxels that are assumed to be at the centre of the fiber bundles, and excludes regions 
that are poorly aligned (Feldman et al., 2010). The FA values for each subject were projected 
onto the mean FA skeleton. Subsequently, FA differences between patients and healthy controls 
were compared at a voxel-wise level, controlling for age and sex. Group differences were 
determined via permutation-based testing in FSL Randomise. Threshold-free cluster 
enhancement (TFCE) was applied, as it provides a voxel-wise significance that is corrected for 
multiple comparisons (Blaschek et al., 2013). This procedure was also conducted for AD and RD 
values.  
To examine the probability that a voxel was a member of a specific tract of interest, 
FSL’s atlasquery function was employed. White matter structures were defined by FSL’s JHU 
white matter tractography atlas (Mori & Zhang, 2006). Only structures which were identified by 
atlasquery as having a minimum probability of 0.5 or greater were included in further analyses. 
FA values were subsequently extracted from the identified white matter tracts via FSL’s fslmaths 
and fslmeants commands.  
4.4.2 Statistical Analyses  
The Shapiro-Wilk and Levene’s tests were used to detect violations of normality and 
homogeneity of variance within the data set. Descriptive statistics were performed for the clinical 
characteristics of our MS sample (i.e., age at disease onset, disease duration, number of relapses, 
EDSS score, use of disease-modifying therapies, T1 and T2 total lesion volumes). Groups were 
compared on demographic variables (age, sex, years education, socioeconomic status), as well as 
on depressive symptom classification, fatigue score, cognitive efficiency composite score, self-
reported strenuous physical activity level, and diffusion parameters using independent samples t-
tests, Mann-Whitney U tests, or Chi-square tests, where appropriate (alpha of 0.05). The 
cognitive outcomes of interest included the cognitive efficiency and neuropsychological 
composite scores; exploratory analyses included measures of fine motor dexterity (i.e., dominant 
and non-dominant hand performance on the 9-hole pegboard task). Outliers (i.e., scores that lie 
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above or below three standard deviations from the normative mean) were trimmed using a 
Winsorizing procedure to three standard deviations above/below the mean. Cognitive 
impairment was defined as performance 1.5 standard deviations below average on three or more 
subtests out of the seven measures that were used to derive the neuropsychological composite 
score. Self-reported strenuous physical activity for each participant was derived from the 
GLTPAQ (i.e., the number of times/week that they participated in over 15 minutes of strenuous 
exercise where their heart beats rapidly). The outcome measures of interest for the DTI data 
included FA, AD, and RD values for the entire white matter skeleton, as well as FA values for 
tracts identified via atlasquery in FSL.  
Pearson partial correlations (two-tailed, adjusted for age; alpha of 0.01) were conducted 
to examine the association between the outcome measures of interest. Supplementary analyses 
examining the relation between diffusion parameters and other MRI measures (i.e., brain and 
thalamic volume, and lesion volume) were also conducted. Exploratory Pearson partial 
correlations (two-tailed, adjusted for age, T1- and T2 lesion volume; alpha of 0.01) were 
conducted to further investigate the association between the cognitive composite scores and 





5.1 Sample Characteristics 
In total, 38 healthy controls and 25 MS patients were recruited and participated in the 
study. Two MS patients (8%) and two controls (5.3%) in the study sample met criteria for 
cognitive impairment. Four MS patients (16%) and two controls (5.3%) met criteria for major 
depression. In order to ensure that the control sample was as representative of a healthy sample 
as possible, the participants who met criteria for cognitive impairment and major depression 
were excluded from any further analyses (N=4), leaving a total of 34 controls. Of note, only 24 
of 34 controls completed the GLPTAQ (because the questionnaire was introduced late into the 
study). MS patients were not excluded from the analyses based on cognitive impairment or self-
reported major depression given that these factors are associated with MS disease pathology 
(Yeh et al., 2009). Upon inspection of T1-weighted MRI scans, two MS patients demonstrated 
large topographical changes in brain structures due to extremely large ventricles or a massive 
lesion. These scans were excluded from the DTI analyses, as previous research has demonstrated 
that pronounced morphological changes in the brain affect the projection step in TBSS and will 
impact the quality of the subject’s alignment to the white matter skeleton (Bach et al., 2014). 
Thus, the overall sample size for the MS group consisted of 23 MS patients.  
Demographic and disease-related characteristics of the sample are reported in Table 2. 
Groups did not differ significantly on measured demographic variables, including age at scan, 
sex, years of education, and parental socioeconomic status (SES). Groups also did not differ on 
measures of fatigue or depression symptom classification. Contrary to the hypothesis, MS 
patients and controls did not differ in self-reported strenuous physical activity. 
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Table 2. Demographic and MS-related characteristics 
 







Mean (SD) Age at scan, yrs 18.45(2.76) 18.55(2.98) 0.03 0.89 
Sex (F/M) 17/6 24/10  0.78a 
Mean (SD) Years education 12.48(2.45) 12.71(2.46) 0.09 0.73 
Mean (SD) SESc 44.63(13.93) 45.54(15.04) 0.06 0.68b 
Mean (SD) Disease Durationd, months 53.39(32.30)    
Mean (SD) Age at MS Onset, years 13.43(2.76)    
Mean (SD) Number of Relapses 4.13(3.18)    
Median (range) Physical Disability 
rating, EDSS 
1.5(1.0-6.0)    
DMT use (Y/N) 18/5    
Depression Symptom Classificatione (n: 
Normal/Mild/Major) – CES-DC 
15/4/4 25/9/0  0.29a 
Mean (SD) Fatiguef 59.52(18.89) 65.81(11.16) 0.51 0.16 
Mean (SD) Level of Strenuous Physical 
Activityg  
2.66(1.86) 2.96(2.03) 0.15 0.76b 
*p0.05; Mean(SD) listed, unless otherwise specified 
**EDSS: Expanded Disability Status Scale; DMT: Disease Modifying Therapy; CES-DC: Centre for Epidemiological Studies 
Depression Scale for Children 
aChi-square test 
dMann-Whitney U test 
cAccording to Barratt Simplified Measure of Social Status 
dMonths since first attack 
eClassification according to Zich et al., (1990) and Ensel (1986); scores of 16-26 are considered indicative of mild depression; 
scores >26 are indicative of major depression 
fBased on the Pediatric Quality of Life Inventory Multidimentional Fatigue Scale; high score indicates fewer symptoms of fatigue 
gAccording to Godin-Shepard Leisure Time Activity Questionnaire 
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Performance on the battery of neuropsychological tests is reported in Table 3. MS 
patients exhibited a significantly lower Full Scale IQ (FSIQ; measured via the WASI) compared 
to healthy controls (p=0.039); however FSIQ was within normal limits for both groups. Patients 
also demonstrated poorer performance on the WASI Vocabulary subtest (p=0.024), as well as 
poorer fine motor coordination on the 9HPT (p=0.018), relative to controls, and only with the 
dominant hand. Groups did not differ significantly on any other cognitive tasks, nor on the 
neuropsychological composite or cognitive efficiency composite scores.  






Cohen’s d p value 
Neuropsychological Composite 0.04(0.75) 0.24(0.55) 0.36 0.26 
Cognitive Efficiency Composite 0.30(0.93) 0.25(1.10) 0.05 0.88 
  SDMT 0.20(1.00) 0.43(1.42) 0.19 0.47 
  WJ-III Decision Speed -0.08(0.83) 0.035(1.05) 0.12 0.66 
  RAVLT – Total Immediate Recall -0.20(1.09) -0.36(1.21) 0.14 0.62 
  RAVLT – Delayed Recall -0.19(1.00) 0.051(1.06) 0.23 0.28a 
  WASI Matrix Reasoning 0.09(0.87) 0.37(0.56) 0.38 0.27a 
  WASI Vocabulary 0.23(0.88) 0.72(0.70) 0.62 0.024 
  WASI Full Scale IQ 0.17(0.77) 0.58(0.63) 0.58 0.039 
  WJ-III Auditory Working Memory 0.26(0.64) 0.32(0.67) 0.09 0.74 
  TMT-A 0.16(1.16) 0.39(0.88) 0.22 0.43a 
  TMT-B -0.40(1.74) 0.13(0.95) 0.38 0.60a 
  Nine Hole Peg Test (Dominant        
Hand) 
-1.17(1.26) -0.44(0.77) 0.70 0.018a 
  Nine Hole Peg Test (Non-Dominant 
Hand) 
-1.10(1.22) -0.79(0.85) 0.29 0.32 
*p0.05; Mean(SD) reported 
aMann-Whitney U test 
Note: SDMT: Symbol Digits Modalities Test; WJ-III: Woodcok Johnson III Test of Cognitive Abilities – 3rd Edition; RAVLT: 





A summary of the MRI characteristics are noted in Table 4. MS patients demonstrated 
smaller normalized white matter volume (p=0.009), and normalized thalamic volume (p<0.001) 
than controls. Normalized grey matter volume and total brain volume did not differ between 
groups. Lesion volume in the MS group was highly variable with T2 volume ranging from 0.006 
to 25.13cm3 (median 4.10) and T1 lesion volume ranging from 0 to 12.1cm3 (median 2.03).  









Brain Volume (z-score) -0.61 (0.84) -0.60 (1.14) 0.010 0.98 
Normalized Grey Matter Volume 
(cm3) 
851.40 (35.74) 872.70 (45.86) 0.052 0.066 
Normalized White Matter Volume 
(cm3) 
691.83 (34.73) 721.16 (40.64) 0.78 0.009a 
Normalized Thalamic Volume z-
score (median & range) 
0.03 (-3.40-1.83) 1.28 (-0.53-2.69) 1.36 <.001 
Total T2 Lesion Volume (cm3; 
median & range) 
4.10 (0.006-25.13) -- -- 
Total T1 Lesion Volume (cm3; 
median & range) 
2.03 (0.00-12.1) -- -- 
*p0.05; Mean(SD) listed, unless otherwise specified
aMann-Whitney U test
5.2 Diffusion Tensor Imaging (DTI) Results 
Results of the TBSS analysis revealed that MS patients demonstrated lower FA compared 
to the control group within the entire white matter skeleton (p<0.001; Figure 2). MS patients 
exhibited lower FA (all p values < 0.006) in several specific white matter tracts, including the 
genu, body, and splenium of the corpus callosum, the bilateral cerebral peduncles, the left 
retrolenticular part of the internal capsule, the left anterior corona radiata, the bilateral superior 
corona radiata, the bilateral posterior corona radiata, the bilateral posterior thalamic radiation, the 
bilateral sagittal stratum, the bilateral external capsule, and the bilateral fornix (Table 5). MS 
patients also demonstrated greater AD compared to the control group in the entire white matter 
skeleton (p<.001), as well as greater RD (p<.001). 
31 
Figure 2. Differences in white matter FA between pediatric-onset MS patients and healthy 
controls. White matter skeleton depicted in green. Areas in which patients demonstrated lower 
FA compared to controls are shown in red and yellow (p<.05, TFCE corrected). 
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Entire white matter skeleton 0.510(0.023) 0.552(0.017) 2.08 <.001 
Corpus Callosum – Genu 0.642(0.042) 0.678(0.031) 1.46 <.001b
Corpus Callosum – Body 0.598(0.047) 0.661(0.032) 1.57 <.001 
Corpus Callosum – Splenium 0.729(0.026) 0.764(0.018) 1.57 <.001 
Cerebral Peduncle – Right 0.666(0.031) 0.707(0.026) 1.43 <.001b
Cerebral Peduncle – Left 0.708(0.030) 0.748(0.029) 1.36 <.001b
Internal Capsule – Right Anterior Limb 0.566(0.026) 0.581(0.028) 0.56 .030 
Internal Capsule – Right Posterior Limb 0.649(0.025) 0.663(0.029) 0.52 .030 
Internal Capsule – Left Posterior Limb 0.652(0.024) 0.657(0.028) 0.19 .22 
Internal Capsule – Right Retrolenticular Part 0.546(0.033) 0.564(0.026) 0.61 .011 
Internal Capsule – Left Retrolenticular Part 0.561(0.030) 0.582(0.029) 0.71 .006 
Corona Radiata – Right Anterior 0.442(0.039) 0.459(0.031) 0.48 .042 
Corona Radiata – Left Anterior 0.420(0.029) 0.444(0.032) 0.79 .003 
Corona Radiata – Right Superior 0.465(0.026) 0.484(0.019) 0.83 .002 
Corona Radiata – Left Superior 0.463(0.022) 0.481(0.018) 0.90 <.001 
Corona Radiata – Right Posterior 0.447(0.028) 0.484(0.027) 1.35 <.001 
Corona Radiata – Left Posterior 0.433(0.028) 0.463(0.022) 1.19 <.001 
Posterior Thalamic Radiation – Right 0.557(0.046) 0.622(0.024) 1.77 <.001b
Posterior Thalamic Radiation – Left 0.555(0.040) 0.621(0.026) 1.96 <.001b
Saggital Stratum – Right 0.503(0.038) 0.550(0.026) 1.44 <.001 
Saggital Stratum – Left 0.514(0.031) 0.553(0.025) 1.38 <.001 
External Capsule – Right 0.449(0.021) 0.466(0.024) 0.75 .004 
External Capsule – Left 0.434(0.019) 0.451(0.020) 0.87 .001 
Fornix – Right 0.496(0.032) 0.554(0.041) 1.58 <.001 
Fornix – Left 0.501(0.046) 0.559(0.027) 1.54 <.001 
Superior Longitudinal Fasciculus – Right 0.464(0.026) 0.478(0.020) 0.60 .025 
Superior Longitudinal Fasciculus – Left 0.464(0.032) 0.482(0.023) 0.65 .017b
Axial Diffusivity (10-3mm2) 
Entire White Matter Skeleton 1.32(0.049) 1.25(0.038) 1.60 <.001 
Radial Diffusivity (10-3mm2) 
Entire White Matter Skeleton 0.604(0.036) 0.544(0.026) 1.91 <.001b
*p0.01; one-tailed: lower FA in MS compared to healthy controls; higher AD and RD in MS compared to controls
aRegions identified according to Atlasquery probability of >0.5
bMann-Whitney U test
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5.3 DTI Correlation Analyses 
Diffusion parameters for the entire white matter skeleton (i.e.., average FA, AD, and RD) 
were not correlated (two-tailed Pearson partial correlations, adjusted for age; alpha of 0.01) with 
any of the following clinical characteristics: disease duration, age of disease onset, number of 
relapses, EDSS score, and fatigue (Supplementary Table 1; Appendix B). FA of specific white 
matter tracts also did not correlate with the above measures.  
5.3.1 MRI Metrics 
The relation between MRI metrics and DTI measures was examined in MS patients (two-
tailed Pearson partial correlations, adjusted for age; alpha of 0.01; Table 6). Brain volume did 
not show any associations with FA, AD, or RD values. Normalized thalamic volume was 
positively associated with FA of the right superior longitudinal fasciculus (r=0.705, p<.001). 
Normalized white matter volume in the brain was negatively associated with FA of the right 
posterior limb of the internal capsule (r=-0.712, p<.001). Normalized grey matter volume was 
negatively associated with FA of the right superior corona radiata (r=-0.563, p=0.008) and with 
FA of the left posterior corona radiata (r=-0.560, p=.008). 
Further associations between lesion volume and DTI measures were examined in MS 
patients (Table 7). Both T1 and T2 lesion volume showed negative correlations with the entire 
white matter skeleton FA (T2: r=-0.613, p=0.003; T1: r=-0.655, p=0.001). Significant negative 
correlations with T1 lesion volumes were also noted with FA of the body and splenium of the 
corpus callosum. The FA of the left superior corona radiata, the bilateral posterior corona radiata, 
and the left sagittal stratum were associated with both T2 and T1 lesion volume; T1 lesion 
volume was additionally associated with FA of the right sagittal stratum (Table 7). T1 and T2 
lesion volume were positively associated with RD (T2: r=0.602, p=0.004; T1: r=0.625, 
p=0.002); no associations between lesion volume and AD were noted. 














Entire white matter skeleton -0.249 -0.067 0.200 -0.249
Corpus Callosum – Genub 0.014 0.276 -0.097 0.179
Corpus Callosum – Body -0.065 0.026 0.100 -0.256
Corpus Callosum – Splenium -0.464* -0.294 0.109 -0.344
Cerebral Peduncle – Rightb -0.163 -0.283 0.148 -0.023
Cerebral Peduncle – Leftb 0.038 -0.036 -0.108 0.149
Internal Capsule – Right Anterior Limb -0.050 -0.063 -0.064 -0.152
Internal Capsule – Right Posterior Limb -0.484* -0.712*** 0.395* -0.520*
Internal Capsule – Left Posterior Limb -0.254 -0.340 0.102 -0.430*
Internal Capsule – Right Retrolenticular Part -0.070 -0.134 0.397* -0.450*
Internal Capsule – Left Retrolenticular Part -0.095 -0.035 0.309 -0.203
Corona Radiata – Right Anterior -0.047 0.200 -0.227 0.045
Corona Radiata – Left Anterior -0.118 0.048 0.083 -0.189
Corona Radiata – Right Superior -0.563** -0.432* 0.262 -0.453*
Corona Radiata – Left Superior -0.545* -0.442* 0.306 -0.518*
Corona Radiata – Right Posterior -0.397* -0.023 0.271 -0.331
Corona Radiata – Left Posterior -0.560** -0.163 0.020 -0.273
Posterior Thalamic Radiation – Rightb -0.267 -0.238 0.394* -0.236
Posterior Thalamic Radiation – Leftb -0.290 -0.040 -0.126 -0.037
Saggital Stratum – Right -0.248 -0.007 0.136 -0.073
Saggital Stratum – Left -0.274 -0.183 0.217 -0.286
External Capsule – Right -0.278 -0.033 0.088 -0.286
External Capsule – Left -0.133 0.177 -0.027 -0.217
Fornix – Right 0.015 0.153 0.334 -0.103
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Fornix – Left -0.122 0.234 0.148 0.195 
Superior Longitudinal Fasciculus – Right -0.257 -0.178 0.705*** -0.228
Superior Longitudinal Fasciculus – Leftb -0.114 0.333 0.525* -0.334
Axial Diffusivity 
Entire White Matter Skeleton -0.041 0.196 -0.210 0.403* 
Radial Diffusivity 




Table 7. Correlations between DTI measures and lesion volume in MS patients 
Total T2 Lesion 
Volume (cm3)b 
Total T1 Lesion 
Volume (cm3)b 
Fractional Anisotropy 
Entire white matter skeleton -0.613** -0.655**
Corpus Callosum – Genub -0.364 -0.400*
Corpus Callosum – Body 0.541* -0.585**
Corpus Callosum – Splenium -0.532* -0.562**
Cerebral Peduncle – Rightb -0.292 -0.329
Cerebral Peduncle – Left 0.179 0.140
Internal Capsule – Right Anterior Limb 0.132 0.069
Internal Capsule – Right Posterior Limb -0.055 -0.009
Internal Capsule – Left Posterior Limb -0.135 -0.096
Internal Capsule – Right Retrolenticular Part -0.297 -0.311
Internal Capsule – Left Retrolenticular Part -0.094 -0.150
Corona Radiata – Right Anterior -0.203 -0.238
Corona Radiata – Left Anterior -0.418* -0.474*
Corona Radiata – Right Superior -0.507* -0.500*
Corona Radiata – Left Superior -0.596* -0.571*
Corona Radiata – Right Posterior -0.707*** -0.720***
Corona Radiata – Left Posterior -0.548** -0.542**
Posterior Thalamic Radiation – Rightb -0.417* 0.423*
Posterior Thalamic Radiation – Leftb -0.497* 0.505*
Saggital Stratum – Right -0.547* -0.583**
Saggital Stratum – Left -0.642** -0.667**
External Capsule – Right 0.080 0.092
External Capsule – Left 0.190 0.155
Fornix – Right -0.327 -0.362
Fornix – Left -0.300 -0.412*
Superior Longitudinal Fasciculus – Right -0.292 -0.281
Superior Longitudinal Fasciculus – Leftb -0.299 -0.306
Axial Diffusivity 
Entire White Matter Skeleton 0.469* 0.459* 
Radial Diffusivity 
Entire White Matter Skeletonb 0.602** 0.625** 
aLog-transformed; r-value reported 
*p0.1(trend); **p<0.01; ***p<0.001
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5.3.2 Cognitive Measures 
Correlations between composite cognitive scores and diffusion parameters were 
examined in MS patients and controls. The cognitive efficiency and the neuropsychological 
composite scores did not significantly relate to any diffusion parameters, in either MS patients or 
controls (Table 8). However, several trends were observed. In the MS group, and contrary to 
expectation, the neuropsychological composite score tended to negatively correlate with FA of 
the bilateral external capsule (Right: r=-0.490, p=0.024; Left: r=-0.496, p=0.022), and the right 
superior longitudinal fasciculus (r=-0.377, p=0.092). These negative associations became 
slightly stronger when controlling for T1 and T2 lesion volume, though significance levels 
remained at trend level (i.e., p>0.01; Table 10). In contrast to the neuropsychological composite 
score, the cognitive efficiency composite tended to positively associate with FA of the body of 
the corpus callosum (r=0.456, p=0.038), and negatively associate with the right superior 
longitudinal fasciculus (r=-0.380, p=0.090). In the control group, only one trend was noted for a 
positive association between the cognitive efficiency composite and FA of the right external 
capsule (r=0.316, p=0.073).  
As an exploratory analysis, correlations between FA and individual measures of cognitive 
efficiency (i.e., SDMT and Decision Speed) were conducted in MS patients.  No associations 
were revealed.  The association between FA and psychomotor speed (Nine-Hole Pegboard Test; 
dominant hand) was also examined given that this measure was significantly lower in the MS 
group relative to controls, and that fine motor dexterity has been previously associated with FA 
of the corpus callosum and association fibres (i.e., cingulum, inferior longitudinal fasciculus, and 
uncinated fasciculus; Zahr, Rohlfing, Pfefferbaum, & Sullivan, 2008). No significant association 
was found (Supplementary Table 2, Appendix B). 
5.3.3 Physical Activity 
When Pearson partial correlations of the DTI data with self-reported strenuous physical 
activity were conducted, several trends (in the expected direction) were observed (Table 9). 
Specifically, in the MS group, physical activity tended to positively associate with FA of the 
right anterior limb of the internal capsule (r=.401, p=.072), and negatively associate with FA of 
the right posterior limb of the internal capsule (r=-.496, p=.022). In the control group, physical 
activity tended to positively associate with FA of the genu (r=.494, p=.017), body (r=.396, 
p=.062), and splenium (r=.400, p=.059) of the corpus callosum, and the left anterior corona 
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radiata (r=.379, p=.074). Additionally, RD of the entire white matter skeleton tended to 
negatively associate with physical activity in controls (r=-.389, p=.066). When controlling for 
T1- and T2-lesion volume in MS patients, positive trends were noted with FA of the genu of the 
corpus callosum (r=0.440, p=0.060) and the right anterior corona radiata (r=0.434, p=0.063), 
and a negative trend with FA of the right posterior limb of the internal capsule (r=-0.398, 
p=0.091; Table 10). 
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Table 8. Correlationsa between DTI measures and composite cognitive scores in MS patients and healthy controls 
Neuropsychological Composite Cognitive Efficiency Composite 
MS (n=23) Control (n=34) MS Control 
Fractional Anisotropy 
Entire white matter skeleton 0.205 -0.051 0.323 0.118 
Corpus Callosum – Genub 0.267 0.024 0.283 0.075 
Corpus Callosum – Body 0.317 -0.110 0.456* 0.074 
Corpus Callosum – Splenium 0.229 -0.075 0.286 0.095 
Cerebral Peduncle – Rightb 0.012 0.276 0.051 0.258 
Cerebral Peduncle – Leftb -0.244 0.138 -0.174 0.304 
Internal Capsule – Right Anterior Limb 0.153 -0.018 0.380 0.067 
Internal Capsule – Right Posterior Limb -0.174 -0.079 -0.193 0.128 
Internal Capsule – Left Posterior Limb -0.264 -0.165 -0.241 0.098 
Internal Capsule – Right Retrolenticular Part -0.041 0.058 0.026 0.148 
Internal Capsule – Left Retrolenticular Part -0.225 -0.219 -0.274 -0.026
Corona Radiata – Right Anterior 0.067 0.037 0.216 0.133
Corona Radiata – Left Anterior 0.212 -0.019 0.362 -0.025
Corona Radiata – Right Superior -0.028 -0.145 0.068 0.074
Corona Radiata – Left Superior 0.042 -0.141 0.115 0.025
Corona Radiata – Right Posterior 0.126 -0.068 0.270 0.206
Corona Radiata – Left Posterior 0.240 -0.120 0.335 0.022
Posterior Thalamic Radiation – Rightb 0.225 0.055 0.323 0.113
Posterior Thalamic Radiation – Leftb 0.195 -0.080 0.242 -0.013
Saggital Stratum – Right -0.020 0.290 0.006 0.280
Saggital Stratum – Left 0.065 -0.160 0.190 0.062
External Capsule – Right -0.490* 0.252 -0.301 0.316*
External Capsule – Left -0.496* -0.051 -0.230 0.108
Fornix – Right -0.256 0.206 -0.084 0.322
Fornix – Left -0.009 -0.073 -0.033 0.118
Superior Longitudinal Fasciculus – Right -0.377* -0.147 -0.380* -0.050
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Superior Longitudinal Fasciculus – Leftb -0.144 -0.063 -0.068 -0.046
Axial Diffusivity 
Entire White Matter Skeleton -0.210 -0.078 -0.307 -0.101
Radial Diffusivity 





Table 9. Correlationsa between DTI measures and level of strenuous physical activity in MS patients and healthy controls 
Level of Strenuous Physical Activity 
MS (n=23) Control (n=24) 
Fractional Anisotropy 
Entire white matter skeleton 0.008 0.219 
Corpus Callosum – Genub 0.313 0.495* 
Corpus Callosum – Body 0.173 0.396* 
Corpus Callosum – Splenium -0.182 0.400* 
Cerebral Peduncle – Rightb -0.203 0.072 
Cerebral Peduncle – Leftb 0.065 0.242 
Internal Capsule – Right Anterior Limb 0.401* 0.323 
Internal Capsule – Right Posterior Limb -0.496* 0.173 
Internal Capsule – Left Posterior Limb -0.333 0.295 
Internal Capsule – Right Retrolenticular Part 0.208 0.097 
Internal Capsule – Left Retrolenticular Part 0.141 0.134 
Corona Radiata – Right Anterior 0.360 0.236 
Corona Radiata – Left Anterior 0.185 0.379* 
Corona Radiata – Right Superior -0.302 0.052 
Corona Radiata – Left Superior -0.346 0.198 
Corona Radiata – Right Posterior -0.164 0.069 
Corona Radiata – Left Posterior -0.245 0.157 
Posterior Thalamic Radiation – Rightb -0.141 -0.165
Posterior Thalamic Radiation – Leftb -0.179 -0.136
Saggital Stratum – Right -0.127 -0.161
Saggital Stratum – Left -0.090 -0.203
External Capsule – Right 0.010 0.002
External Capsule – Left 0.112 0.070
Fornix – Right 0.225 -0.239
Fornix – Left 0.067 -0.159
Superior Longitudinal Fasciculus – Right -0.318 0.080
Superior Longitudinal Fasciculus – Leftb -0.044 0.222
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Axial Diffusivity 
Entire White Matter Skeleton 0.099 -0.267
Radial Diffusivity 















Entire white matter skeleton -0.049 -0.049 0.067 
Corpus Callosum – Genub 0.104 0.007 0.440* 
Corpus Callosum – Body 0.115 0.173 0.210 
Corpus Callosum – Splenium 0.093 0.099 -0.151
Cerebral Peduncle – Rightb -0.028 0.015 -0.152
Cerebral Peduncle – Leftb -0.183 -0.073 0.046
Internal Capsule – Right Anterior Limb 0.090 0.355 0.330
Internal Capsule – Right Posterior Limb -0.070 0.023 -0.398*
Internal Capsule – Left Posterior Limb -0.285 -0.297 -0.296
Internal Capsule – Right Retrolenticular Part -0.129 -0.081 0.367
Internal Capsule – Left Retrolenticular Part -0.210 -0.290 0.221
Corona Radiata – Right Anterior -0.242 -0.271 0.434*
Corona Radiata – Left Anterior -0.074 -0.078 0.199
Corona Radiata – Right Superior -0.231 -0.182 -0.226
Corona Radiata – Left Superior -0.153 -0.143 -0.311
Corona Radiata – Right Posterior -0.055 -0.082 -0.081
Corona Radiata – Left Posterior 0.069 0.105 -0.257
Posterior Thalamic Radiation – Rightb 0.055 0.098 -0.108
Posterior Thalamic Radiation – Leftb 0.013 -0.041 -0.155
Saggital Stratum – Right -0.087 -0.059 0.028
Saggital Stratum – Left -0.198 -0.156 0.012
External Capsule – Right -0.521* -0.360 0.062
External Capsule – Left -0.560* -0.337 0.018
Fornix – Right -0.332 -0.183 0.314
Fornix – Left -0.049 -0.114 0.101
Superior Longitudinal Fasciculus – Right -0.392* -0.319 -0.085
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Superior Longitudinal Fasciculus – Leftb -0.171 -0.096 0.015 
Axial Diffusivity 
Entire White Matter Skeleton 0.040 0.118 0.246 
Radial Diffusivity 




5.4 Exploratory Correlations with Normalized White Matter Volume 
Exploratory Pearson partial correlations (two-tailed, adjusted for age; alpha of 0.01) 
revealed that normalized white matter volume was associated with self-reported strenuous 
physical activity in controls (r=0.531, p=0.009); a trend for a positive association was noted in 
MS patients (r=0.442, p=0.045; Table 11). No associations were found with normalized white 
matter and the neuropsychological composite, or cognitive efficiency. Exploratory analyses 
examining the relation between normalized white matter and FA, AD, and RD values of the 
entire white matter skeleton also did not reveal any significant associations.  
Table 11. Correlationsa between normalized white matter volume and strenuous physical 
activity, cognitive outcomes, and average DTI measures in MS patients and healthy controls 
Normalized White Matter Volumeb
MS (n=23) Control (n=24) 
Strenuous Physical Activity 0.442* 0.531** 
Neuropsychological Composite 0.061 -0.032
Cognitive Efficiency -0.041 0.013
Average Fractional Anisotropyc -0.067 0.146
Average Axial Diffusivityc 0.196 -0.038








The purpose of this study was to examine the relation between physical activity, white 
matter integrity and cognitive efficiency in pediatric-onset multiple sclerosis. As expected, 
differences in diffusion parameters of the white matter skeleton were observed between groups, 
with patients consistently exhibiting indices of lower white matter integrity. Total T1 and T2 
lesion volumes correlated with several white matter tracts. Associations between white matter 
integrity and cognitive composite scores were not observed. While self-reported strenuous 
physical activity did not correlate with diffusion parameters of white matter integrity, it was 
significantly associated with normalized white matter volume in controls, and demonstrated a 
trend toward a positive association with white matter volume in patients.  
6.1 Sample Characteristics 
Similar to previous studies, our sample of pediatric-onset MS patients was comparable to 
other study samples in the literature with respect to disease duration, disability, and relapse rate 
(Amato et al., 2009; MacAllister, Boyd, Holland, Milazzo, & Krupp, 2007; Till et al., 2012). 
Patients and controls did not differ in age, sex ratio, years of education, or SES. Inconsistent with 
previous literature (Amato et al., 2010; Grover et al., 2015), the current sample of patients did 
not differ from controls with respect to mood, fatigue or level of self-reported strenuous physical 
activity. Given that increased physical activity is known to impart positive effects on both mood 
and fatigue (Babyak et al., 2000; Blumenthal et al., 2009; Jerstad, Boutelle, Ness, & Stice, 2010), 
it is possible that higher levels of physical activity contributed to the similarities noted between 
patients and controls in this study.  
Notably, groups differed with respect to vocabulary, fine motor dexterity, and IQ. This is 
consistent with previous work conducted in independent samples of pediatric-onset MS patients 
(Till et al., 2011; Till et al., 2013). It should be noted, however, that even though MS patients 
scored lower on these measures, they still fell within the age-expected range. As such, this 
sample of MS patients is relatively cognitively intact in comparison to previous studies (Amato 
et al., 2009; Till et al., 2011).  
Finally, while lesion volume was quite variable among patients, they were comparable to 
what has been observed in other pediatric-onset MS samples (Till et al., 2011, 2012). Moreover, 
MS patients demonstrated smaller normalized thalamic volume and normalized white matter 
volume. Previous research has noted that thalamic volume is sensitive to disease pathology in 
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pediatric onset MS (Mesaros et al., 2008; Till et al., 2011, 2012), though there is less consensus 
with regards to the clinicopathological relevance of white matter volume (Till et al., 2011; 
Tortorella et al., 2006). While it is generally understood that white matter is negatively impacted 
by inflammation due to MS disease activity, the impact on the thalamus may reflect Wallerian 
degeneration, given the number of white matter projections originating from this structure 
(Mesaros et al., 2008). Although slightly lower grey matter volume was noted in patients, groups 
did not differ significantly in this MRI metric. This finding may reflect a lack of significant 
secondary disease mechanisms, such as Wallerian degeneration, in the grey matter of this 
sample, however this conclusion is purely speculative.  
6.2 Group differences in diffusion parameters 
The first aim of this study was to examine differences in white matter integrity between 
pediatric-onset MS patients and healthy controls, using tract-based spatial statistics (TBSS). This 
method for examining diffusion tensor imaging data has been validated as a reliable measure for 
investigating whole brain changes in white matter microstructure (Smith et al., 2006).  
In accordance with the study’s hypothesis, differences in diffusion parameters were noted 
between patients and controls, with patients exhibiting indices of lower white matter integrity. 
Specifically, lower FA in the entire white matter skeleton, as well as in several white matter 
tracts was noted in patients. FA is the primary index of white matter integrity in DTI analyses, 
and provides an indirect measure of myelination (Feldman et al., 2010). Indeed, previous studies 
have noted that the FA of myelinated and non-myelinated fibres differ significantly, with lower 
FA in lesions compared to normal-appearing white matter  (NAWM; Sbardella, Tona, Petsas, & 
Pantano, 2013; Werring, Clark, Barker, Thompson, & Miller, 1999).  The findings of this study 
are consistent with previous literature which has noted decreased FA in pediatric-onset MS 
patients (Absinta et al., 2010; Akbar et al., 2016; Blaschek et al., 2013; Rocca, Valsasina, et al., 
2014; Rocca, Absinta, et al., 2014; Tillema et al., 2012; Vishwas et al., 2013; Vishwas, Chitnis, 
Pienaar, Healy, & Grant, 2010). Similar to Akbar et al., (2016) significantly lower FA values 
were observed in the subfields of the corpus callosum, the posterior thalamic radiation, the 
sagittal stratum, and the superior/posterior corona radiata. The aforementioned tracts are all 
major white matter tracts that may be vulnerable to disease pathology, given their proximity to 
areas of the brain with high lesional probability (e.g., periventricular regions; Yeh et al., 2009). 
Notably, previous DTI studies have observed that the corpus callosum (i.e., the major white 
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matter structure in the brain connecting the cerebral hemispheres) is particularly impacted by MS 
disease pathology (Akbar, Giorgio, et al., 2016; Blaschek et al., 2013; Rocca, Absinta, et al., 
2014; Tillema et al., 2012; Vishwas et al., 2013). Moreover, given that lesions were not removed 
in these analyses to examine NAWM, the FA values extracted may have been impacted by the 
presence of lesions in these tracts.  
This study noted additional reductions in the FA values of the anterior corona radiata, 
cerebral peduncle, retrolenticular part of the internal capsule, external capsule, and fornix, 
suggesting that widespread damage of white matter is present early in the disease course. This is 
consistent with previous studies which have observed lower FA in more diffuse white matter 
tracts of the brain, including the posterior limb of the internal capsule, the cerebral peduncle, and 
association fiber system (including the fornix and the superior longitudinal fasciculus; Vishwas 
et al., 2010; 2013). The extent of FA reductions observed in patients in this study highlights the 
sensitivity of the TBSS technique in detecting MS disease pathology.  
Consistent with Akbar et al., (2016) greater RD in the entire white matter skeleton was 
noted in patients, relative healthy controls. In addition, greater AD was observed in patients, 
contrary to Akbar et al., (2016) who did not note a group difference in this metric. As mentioned 
previously, higher AD and RD values are indicative of axonal loss (Aung, Mar, & Benzinger, 
2013; Song et al., 2002) and demyelination (Klawiter et al., 2011), respectively. The discrepancy 
between this analysis and that conducted by Akbar et al., (2016) suggests that reduced white 
matter integrity in this population is not purely explained by demyelination, but that axonal loss 
is an additional contributing factor. Postmortem examination of the MS brain has noted 
decreased axonal density in lesioned tissue (Van Waesberghe et al., 1999), though notable 
exceptions exist (Schmierer et al., 2007). 
It is important to acknowledge that of the aforementioned studies, different methods for 
investigating differences in white matter integrity were employed (i.e., voxel-based 
morphometry, tractography, and TBSS). Given the heterogeneity in how these different methods 
analyze DTI data, comparisons between studies employing different measures should be drawn 
with caution. Further examination of the differences between such methods will be explored in 
subsequent sections of this discussion.  
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6.2.1 White matter integrity and lesion volume 
It should be further noted that several studies also observed lower FA values in NAWM 
of pediatric-onset MS patients when compared to healthy controls (Bethune et al., 2011; Longoni 
et al., 2017; Till et al., 2011; Tillema et al., 2012; Tortorella et al., 2006; Vishwas et al., 2013, 
2010a). According to the current results, it appears that differences in white matter integrity 
between patients and controls may be associated with lesion volume.  
Indeed, higher T1- and T2-lesion volume correlated with lower FA in many tracts in 
which group differences were also noted (though some were trends). These included, the body 
and splenium of the corpus callosum; the bilateral anterior, posterior, and superior corona 
radiata; the bilateral posterior thalamic radiation; and the bilateral sagittal stratum. In adult MS, 
previous studies have co-localized FA results with lesion maps and have noted lower FA in focal 
white matter lesions defined by T2-weighted images (Bammer et al., 2000; Roosendaal et al., 
2009). FA has been noted as a more sensitive metric for detecting tissue damage than MD, as its 
values have been shown to decrease according to the severity of tissue disruption (Bammer et al., 
2000), and FA reductions in the corpus callosum and corona radiata have been associated with 
T2 lesion volume (Roosendaal et al., 2009). This study noted stronger associations between T1-
lesion volume and FA, compared to T2 lesion volume. This is consistent with previous research 
which has noted the most pronounced alterations in diffusion parameters in T1 hypointense 
lesions, given that they are characterized by more severe tissue injury (Bammer et al., 2000; 
Droogan et al., 1999; Filippi, 2001; Rocca, Cercignani, Iannucci, Comi, & Filippi, 2000).   
T1 and T2 lesion volumes were also negatively correlated with FA in the entire white 
matter skeleton, and showed a positive association with RD, and a trend for a positive 
association with AD. Indeed, while FA has been shown to be more sensitive to pathological 
damage than MD ( i.e., an index of myelin loss comprising AD and RD; Scanderbeg et al., 2000; 
Werring et al., 1999), both FA and MD are impacted by T2 lesions in adult MS (Cercignani et 
al., 2000; Christiansen et al., 1993; Droogan et al., 1999; Filippi et al., 2000; Larsson, Thomsen, 
Frederiksen, Stubgaard, & Henriksen, 1992). Previous research examining diffusion parameters 
in pediatric-onset MS patients have also noted a relation between lesion burden and DTI 
abnormality (Bethune et al., 2011). Specifically, greater total T2-lesion volume has been 
associated with lower FA in the NAWM of the corpus callosum and of the average supratentorial 
hemispheric NAWM (Bethune et al., 2011). In this study, both T1- and T2-lesion burden appear 
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to be linked to the degree of DTI abnormality. This is consistent with previous studies in 
pediatric-onset MS (Bethune et al., 2011), though notable exceptions exist (Absinta et al., 2010).  
In adult MS, it is accepted that lesion volume is poorly correlated with physical disability 
(Barkhof, 1999; Yeh et al., 2009). These findings reflect the limitations of examining lesion 
volume in MS. T2-weigthed images are non-specific, and cannot distinguish between lesions 
caused by inflammation, edema, or axonal loss (Zivadinov & Bakshi, 2004). Moreover, active 
demyelination may be identified by contrast enhancement in T1-weighted images; however, such 
enhancement is not a reliable index of disease progression or permanent injury (Filippi et al., 
1997; Lai et al., 1996). A critical limitation to examining lesion volume in MS is also that it is 
unable to specify whether high lesion volume is indicative of a very large lesion, or multiple 
diffuse lesions. Indeed, some patients with only modest lesion volumes will present with 
advanced neurologic disability, whereas patients with many or enlarging lesions may show 
minimal disability (Thompson et al., 1990). However, given these arguments, when T1 and T2 
lesion volume were controlled for, no associations between FA and the cognitive composite 
scores were observed. As such, it is not likely that lesion volume had a strong effect on this 
association, but rather that the structural damage observed in our sample was not sufficiently 
severe to produce a more profound impact on cognition. 
6.3 Indices of white matter integrity not associated with cognitive measures, MRI metrics 
Inconsistent with previous research, this study did not observe any associations between 
indices of white matter integrity and the cognitive composite scores, though a trend was 
observed between higher FA of the body of the corpus callosum and higher cognitive efficiency 
composite in the MS group. In adult MS, several studies have noted that tract injury identified by 
abnormal diffusion parameters is associated with cognitive dysfunction (Dineen et al., 2009; 
Hulst et al., 2013; Rovaris et al., 2002; Sbardella et al., 2013; Yu et al., 2012). In pediatric-onset 
MS, altered diffusion parameters, particularly lower FA in the corpus callosum, have been 
associated with reduced attentional control (Todorow, DeSouza, Banwell, & Till, 2014), slower 
processing speed (Bethune et al., 2011), and poorer math performance (Till et al., 2011). It is 
worth noting that in two of the aforementioned studies that observed an association between 
cognitive measures and DTI abnormalities of the corpus callosum, only NAWM was examined 
(Bethune et al., 2011; Till et al., 2011). In the current study, lesions were included in the 
analyses, as previous research has demonstrated that the extent of T2 lesions in white matter 
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tracts had more power in identifying neuropsychological impairment, over and above NAWM 
(Mesaros et al., 2012). Moreover, none of the aforementioned pediatric studies examined white 
matter integrity via the TBSS technique; rather, tractography and ROI-based methods were 
employed. However, there is evidence in the adult MS literature of an association between 
abnormal diffusion parameters analyzed via TBSS and cognitive dysfunction (Dineen et al., 
2009; Hulst et al., 2013; Yu et al., 2012). As noted in the pediatric-onset population, the 
strongest associations have been observed in the posterior thalamic radiation, the sagittal stratum, 
and the corpus callosum (Yu et al., 2012), with lower FA related to slower processing speed 
(Dineen et al., 2009; Yu et al., 2012) as well as poorer visual and verbal learning and memory 
(Dineen et al., 2009).  
Based on the literature in adult MS, TBSS appears to be an appropriate technique for 
identifying associations between white matter integrity and cognitive dysfunction. It should be 
noted, however, that the sample of MS patients in this study was relatively cognitively intact, 
which may have also masked any relations between the cognitive outcomes of interest and the 
diffusion parameters. Notably, Hulst et al., (2013) observed that the FA skeleton in cognitively 
preserved adult MS patients was affected to a lesser degree than in the cognitively impaired 
patients (49% versus 76% of white matter affected, respectively). In cognitively-preserved 
pediatric MS patients, the white matter damage may not be sufficiently extensive to demonstrate 
a relation with cognitive ability. Perhaps if this sample were followed over time, the association 
would become more pronounced. Schoonheim, Meijer, & Geurts (2015) propose a hypothesis for 
the development of cognitive impairment in MS. They note that in the early stages of MS, 
structural damage is low, allowing for neural networks to continue functioning efficiently. As 
such, patients remain cognitively intact for some time. However, over time, as structural damage 
accumulates, networks become less efficient, and eventually, a threshold is reached and it is 
likely that cognitive impairment ensues (Figure 3).  
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Figure 3. Hypothesis for the development of cognitive impairment in MS. Figure as 
originally published in Schoonheim, Meijer & Geurts (2015), Front Neurol, 6:82.  
Given that the patients in this sample are early in the stages of MS, it is probable that the 
structural damage caused by the disease is not yet significant enough to produce any negative 
impact on cognition. These patients are likely able to compensate for structural damage through 
the reorganization of neural networks necessary for cognitive processes. Rocca et al. (2015) 
noted that the structural damage contributing to cognitive impairment in pediatric-onset MS is 
likely driven by white matter damage, rather than cortical lesion volume or number. Indeed, they 
observed that while cognitively preserved and cognitively impaired pediatric-onset MS patients 
did not differ in terms of lesion volume/number, cognitively impaired patients had significantly 
lower white matter volume. Moreover, in another study, the same group observed that while 
cognitively preserved pediatric onset MS patients showed no DTI abnormalities compared to 
controls, the cognitively impaired group (defined by scoring greater than two standard deviations 
below the mean on two or more neuropsychological tests) demonstrated a diffuse pattern of 
decreased FA and increased RD in the corpus callosum, cingulum, fornix, and parieto-occipital 
white matter (Rocca et al., 2014). This study also noted functional connectivity differences 
between groups, such that cognitively impaired patients showed decreased functional 
connectivity of the right precuneus, whereas cognitively preserved patients demonstrated 
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increased functional connectivity of the right anterior cingulate cortex. This is consistent with 
Akbar et al. (2016) who noted increased functional connectivity of the precuneus in cognitively 
preserved patients relative to healthy controls, particularly in connections with the anterior 
cingulate cortex, frontal medial cortex, and cerebellum, though not all studies have observed 
differences in resting state functional connectivity between cognitively impaired and cognitively 
preserved patients (Rocca, Valsasina, et al., 2014).  
In line with the hypothesis proposed by Schoonheim, Meijer & Geurts (2015), these 
studies suggest that, despite structural damage, cognitively preserved patients may be recruiting 
compensatory mechanisms to maintain cognitive functioning. Such studies highlight the pivotal 
role that white matter damage plays in the pathogenesis of cognitive impairment in these 
patients, and demonstrate that the severity of such impairment may be more associated with 
posterior regions of the brain, where structural damage is more pronounced. Given these 
findings, the widespread structural pathology which was observed in this study through DTI may 
have been counteracted by the reorganization of networks and the use of compensatory 
mechanisms (e.g., increased functional connectivity). As such, the association between structural 
pathology and cognition may have been masked, and patients presented as relatively cognitively 
intact.  
Nonetheless, trends were noted in MS patients indicating that lower FA of the bilateral 
external capsule and the right superior longitudinal fasciculus associated with higher 
neuropsychological composite scores. A pattern of negative association between other MRI 
metrics (i.e., grey/white matter volume and brain volume) were observed with FA of the corona 
radiata and the internal capsule. Indeed, it does not seem logical that increased volume in other 
MRI metrics should associate with decreased white matter integrity, nor that lower FA would 
associate with stronger neuropsychological function. However, when interpreting potentially 
spurious results, it is important to consider the limitations of the TBSS analysis. Of note, TBSS 
makes use of the FA map and discards orientation information captured in the diffusion data; this 
creates complications in pathways where different structures merge, such as in the corona radiata 
(Bach et al., 2014). Moreover, tract specificity of the projection step in the analysis is not fully 
understood (Bach et al., 2014). Indeed, there is a body of literature that exists which cautions 
against over-interpretation of associations (especially if they are at the trend level) that are noted 
with specific tracts identified via TBSS (Bach et al., 2014; Leow et al., 2009; Vos, Jones, 
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Jeurissen, Viergever, & Leemans, 2012). Such limitations may have also contributed to the lack 
of association observed between self-reported strenuous physical activity and diffusion 
parameters.  
6.4 Self-reported physical activity is not associated with diffusion parameters, but is correlated 
to white matter volume  
Contrary to the hypotheses, diffusion parameters did not correlate with self-reported 
strenuous physical activity in either pediatric-onset MS patients or healthy controls. This is 
inconsistent with previous literature in healthy children and adolescents which has noted that 
higher-fit individuals have greater white matter integrity, particularly of the corpus callosum 
(Chaddock-Heyman et al., 2014). However, even within healthy populations, there is limited 
research examining the impact of physical activity on white matter integrity in children and 
adolescents, and most of this research has been conducted in older and aging adults. While the 
beneficial effects of exercise on white matter integrity have been noted in the adult MS 
population (Dalgas & Stenager, 2012; De Giglio et al., 2016; Ibrahim et al., 2011; Prakash, 
Patterson, Janssen, Abduljalil, & Boster, 2011; Prosperini et al., 2014; Prosperini, Piattella, 
Giannì, & Pantano, 2015; Rasova et al., 2015), little is known with regard to the effect of 
exercise on the brain in the pediatric population.  
Notably, Grover et al. (2015) observed that pediatric-onset MS patients participated in 
less vigorous physical activity than healthy age- and sex-matched controls, and that increased 
physical activity in the MS group was associated with decreased lesion volume. In the current 
study sample, no between group differences in self-reported strenuous physical activity were 
noted. Moreover, the range of self-reported strenuous physical activity was large in the MS 
population (0-7 times/week), with no consistent pattern between level of physical activity and 
FA values. This observation highlights the limitations in conducting a cross-sectional study of 
this nature. For example, it is unclear whether the MS patients who reported participating in 
more strenuous physical activity have been doing so for a long time, and as such have higher FA 
in the tracts of interest, or whether they have just recently begun exercising more regularly, and 
subsequently still demonstrate lower FA values.  
Self-reported strenuous physical activity also did not associate with the cognitive 
composite scores in either group. Previous research has noted that acute and chronic exercise 
regimens may exert different effects on executive functioning, given that most research 
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examining these constructs have studied the positive effects of acute exercise on higher-level 
cognitive processes, but very few have investigated the impact of a chronic exercise regimen 
(Verburgh, Konigs, Scherder, & Oosterlaan, 2013). Additionally, not all forms of exercise are 
thought to have equivalent benefits on brain health. For instance, Diamond (2015) notes that for 
physical activity to have an effect on children’s executive functions, it must be cognitively-
engaging (e.g., sports that involve strategy, such as basketball). Moreover, studies examining the 
effect of exercises that involve character development (e.g., traditional martial arts) or 
mindfulness (e.g., yoga) are more effective in improving children’s executive functions than 
exercise alone (e.g., running; Lakes & Hoyt, 2004; Manjunath & Telles, 2001). The current study 
did not gather data on the type of physical activity that participants were engaging in. Such 
information would have utility in future research in evaluating the effectiveness of physical 
activity on cognition in this population. In addition, physical activity was not associated with 
decreased lesion volume in this study, contrary to previous research (Grover et al., 2015). 
Methodological limitations may have been responsible for masking the expected result, such as 
insensitivity of the physical activity measure, or low power.  
However, partial correlations controlling for age revealed a pattern in the corpus 
callosum in healthy controls that was not evident for MS patients. Specifically, FA of all 
subfields of the corpus callosum positively associated with greater levels of self-reported 
strenuous physical activity. Additionally, increased levels of physical activity were associated 
with lower RD in the entire white matter skeleton. These patterns were not observed in MS 
patients, suggesting that strenuous physical activity may have a differential effect on brain 
structure in patients and controls. Trends in the internal capsule were noted for MS patients; 
however, they demonstrated an inconsistent pattern, with a positive association noted between 
FA of the right anterior limb and strenuous physical activity, and a negative association with the 
FA of the right posterior limb. Such inconsistent results call into question the reliability of these 
findings. It should also be emphasized that these patterns were non-significant, further cautioning 
against over-interpretation of the results. 
In controls, a consistent and significant positive association was noted between physical 
activity and normalized white matter volume. This relation was observed in MS patients only 
when analyses were not covaried for age. As such, it appears as though an association between 
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physical activity and white matter exists, though it is driven by age in the MS group, and that this 
association is specific to white matter volume rather than white matter microstructure.  
Indeed, the findings of the current study call into question the utility of the TBSS method 
in identifying associations between diffusion parameters and lifestyle factors. In previous 
literature, spurious correlations between improvement in motor performance and lower FA in 
several white matter tracts have been observed (Taubert et al., 2010). Taubert et al. (2010) 
employed the VBM method for extracting indices of white matter integrity following two 
sessions of practice on a balancing task. Contrary to expectations, decreases in FA were noted in 
association with learning-related improvements in motor performance. Upon further 
investigation, it was observed that the regions which showed such negative correlations were 
also areas of the brain where evidence for crossing fibers was observed (i.e., left prefrontal and 
right parietal white matter regions). As such, the negative correlations that were noted may be a 
product of the limitations of DTI analyses, rather than a representation of a true, meaningful 
association.  
Previous research has noted that FA correlates with other MRI metrics including white 
matter volume (Kochunov et al., 2007), though there is limited research that has examined this 
relation. Indeed, there is an even greater literature that critiques DTI as a method, particularly the 
TBSS technique. Moreover, given that MS is an illness affecting white matter, special 
consideration into the limitations of this technique, specifically within this clinical population, is 
warranted. Identifying such limitations may provide insight as to why the expected associations 
were not observed in this study.  
6.5 Methodological considerations 
6.5.1 Is DTI an accurate measure of white matter integrity? 
Since its conception, DTI has grown in popularity, particularly for evaluating disease 
pathology in illnesses of the brain. However, several studies have highlighted the limitations to 
this technique, the questions it can and cannot answer, and where it fails as a method (Assaf & 
Pasternak, 2008; Leow et al., 2009; Sbardella et al., 2013; Vos et al., 2012). While anisotropy 
measures do change significantly when myelin is damaged or absent (such as in MS), the exact 
contribution of myelin to the DTI signal cannot be fully determined (Assaf & Pasternak, 2008). 
Indeed, FA values will show a similar pattern of reduction in demyelination, edema, gliosis, and 
inflammation, suggesting that it is a non-specific metric. Moreover, the FA metric is confounded 
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by the fact that it is a measure of several factors, including the directionality of individual fibres 
(which may be influenced by myelin thickness), as well as the number of dominant fibre 
directions (i.e. the density of fibres; Leow et al., 2009). This begs the question: is myelin a 
crucial factor for obtaining anisotropy measures from the DTI signal? The answer to this 
question remains largely unclear.    
The assumptions of the DTI model also contribute to its limitations. The major 
assumption is that a single diffusion tensor is sufficient to characterize each voxel (Assaf & 
Pasternak, 2008). In this study, a voxel size of 2x2x3 mm3 was employed. Tens of thousands of 
axons likely make up each voxel, and it is unlikely that a single diffusion tensor is representative 
of them all. As a result, the tensor is an average of the fibres in each voxel. Specifically, the DTI 
model fails in regions where the tensor averages areas where white/grey matter or white 
matter/CSF are found in the same voxel (termed “tissue partial volume”), or areas where white 
matter fibres cross in the same voxel (termed “white matter partial volume; Assaf & Pasternak, 
2008; Leow et al., 2009; Vos et al., 2012). Some studies have noted that diffusion parameters are 
adequate for modelling tracts with a single dominant orientation (e.g., the corpus callosum), but 
that it is not suitable for more complex fibres (e.g., the corona radiata; Gunnarsson, 2014). This 
calls into question the interpretability of diffusion parameters in a variety of white matter tracts, 
especially in clinical populations where white matter is affected, such as MS.  
6.5.2 Are diffusion parameters an accurate index of MS pathology? 
Indeed, diffusivity patterns differ according to MS phenotype and within different lesions 
and tissue types (Sbardella et al., 2013). A variety of methodological approaches have been 
employed to study diffusion parameters in MS, and to study different types of tissue damage. 
DTI has proven to be useful for detecting areas of demyelination in MS that are undetected by 
conventional MRI (Sbardella et al., 2013), and post-mortem research in MS has confirmed the 
association between diffusion parameters and histologically-derived measures of tract 
myelination (Kolasinski et al., 2012; Schmierer et al., 2007). Moreover, many studies have 
concluded that FA, AD, and RD are good measures for disease pathology (Prosperini et al., 
2014).  
As mentioned previously, many studies have examined cortical NAWM, and have 
detected widespread DTI abnormalities in this tissue type, such as decreased FA and increased 
MD, in both adult MS (Bammer et al., 2000; Cercignani et al., 2000; O Ciccarelli, Werring, 
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Barker, Thompson, & Miller, 2001; Droogan et al., 1999; Filippi, 2001; Filippi et al., 2000; Guo, 
Jewells, & Provenzale, 2001; Rocca et al., 2000), and in pediatric-onset MS (Bethune et al., 
2011; Longoni et al., 2017; Till et al., 2011; Tillema et al., 2012; Tortorella et al., 2006; Vishwas 
et al., 2013, 2010a). Moreover, one study noted an FA gradient in adult MS patients, with lower 
FA values closer to lesions, and higher values further from the lesions (Guo et al., 2001). Most 
studies have noted that the degree of damage to NAWM varies according to the severity of 
pathology and as the disease worsens over time (Sbardella et al., 2013). Notably, Longoni et al., 
(2017) observed that over a median follow-up period of 4.4 years, pediatric-onset MS patients 
failed to show age-expected white matter development and a progressive loss of tissue integrity 
(indexed by decreases in FA and increases in MD of NAWM over time). The current study did 
not examine diffusion parameters in NAWM, as the impact of lesioned tissue on cognitive ability 
was of interest. Interestingly, the examination of NAWM in MS has been critiqued, with some 
suggesting that it may have limited value early on in the disease process, as the effects of the 
disease may be less pronounced (Sbardella et al., 2013). 
Given the consistent results noted in the literature examining diffusion parameters in MS, 
it appears as though this is a valid method for investigating MS disease pathology. However, 
these findings do not acknowledge several limitations that arise in DTI analysis. The remainder 
of this discussion will examine the limitations of DTI analysis in MS, particularly with the TBSS 
method, which was employed in this study.  
6.5.3 Limitations of TBSS 
TBSS is the most popular approach for performing voxel-wise DTI analyses. This 
technique was developed to address alignment-related problems associated with voxel-based 
morphometry (VBM) and tractography, and as a method that could investigate the entire brain 
(as opposed to pre-delineated tracts of interest) in a fully automated manner (Smith et al., 2006). 
VBM is limited by alignment inaccuracies and smoothing extent, and tractography methods are 
limited in terms of finding the principal direction of a tract (i.e., in locations where there are 
crossing fibers, low signal-to-noise ratio and poor spatial resolution, small non-detectable fibers, 
and other distortions in the brain; Smith et al., 2006, 2007). TBSS was designed to overcome 
these problems in order to improve the sensitivity, objectivity, and interpretability of the results.  
A major concern of TBSS analysis is the ongoing debate regarding its anatomical 
specificity (Bach et al., 2014). Since TBSS discards orientation information and makes use only 
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of the FA map when projecting onto the FA skeleton, complications arise in terms of 
distinguishing between adjacent, but differentially oriented fibre bundles with similar FA values; 
for example, between the body of the corpus callosum and the corona radiata (Bach et al., 2014). 
Because the TBSS technique discards the orientation information, it becomes difficult to 
distinguish between such tracts, and as a result, the skeletonization process will cause these 
fibres to collapse onto one another. Bach et al. (2014) noted significant group differences in FA 
in regions where voxel misalignment had occurred, and that small tracts were more susceptible 
to such errors (e.g., the fornix). Given that the threshold-free cluster enhancement (TFCE) 
correction depends on statistical support from adjacent voxels in order to detect group 
differences, voxel misalignment that causes structures to collapse onto one another or merge 
would dramatically alter the significance map. In addition to this, group differences were 
observed in noise-induced structures which were otherwise anatomically-meaningless, 
highlighting the risk of false positives in TBSS analyses. Finally, the authors examined the extent 
to which the results obtained through TBSS analyses depend on user-specified settings. They 
found that different results were obtained depending on the registration target used. In FSL, the 
options for registration targets are the FMRIB58 template (provided by the software), or a study-
specific target, where the most representative subject from the group is used as the registration 
target. The authors noted that a smoother FA map and a clearer depiction of white matter 
structures were obtained from registration to the FMRIB58 target, rather than the study-specific 
target. Indeed, a similar observation was noted for the data in the current study, and as a result, 
the FMRIB58 target was used.  
While it has been validated as an accurate measure of white matter microstructure in MS, 
it is evident that the TBSS technique has its limitations. Additionally, based on these critiques, it 
is plausible that the spurious associations noted in the current study may have been due to 
alignment error, or a liberal statistical correction. Indeed, the regions which demonstrated 
unexpected patterns of association with the cognitive and MRI data are tracts that are smaller 
(i.e., the external capsule) and where tracts change in orientation (i.e., the corona radiata), or 
cross other tracts (i.e., the posterior thalamic radiation). Given that several unexpected negative 
associations were observed in this study, the interpretation of these results should be done with 
caution. As such, investigating tracts that are more robust against the limitations of TBSS 
analysis (i.e., corpus callosum, and large association fibres, such as the superior longitudinal 
60 
fasciculus), should be emphasized more than those which are vulnerable to alignment error (i.e., 
projection fibres, such as the corona radiata and tracts originating from the thalamus). However, 
the between group results are consistent with the findings in published research that examined 
the same cohort of MS patients (Akbar et al., 2016). As such, TBSS-derived diffusion parameters 
identify some aspects of disease pathology, at least in major white matter tracts that are more 
vulnerable in MS (e.g., corpus callosum). It is also noteworthy that employing the TBSS 
technique provided information on whole brain white matter microstructure, and our analyses 
were not limited to specific tracts or voxels of interest (as in VBM and tractography analyses). 
Given the limitations outlined in this section, the group differences and associations with average 
FA, AD, and RD of the entire white matter skeleton are likely the most informative results of this 
study. Nevertheless, using multiple methods for measuring white matter pathology along with 
global white matter volume may provide a clearer understanding of the effect of MS on white 
matter microstructure, and its association with cognitive ability. 
6.5.4 White matter volume 
Indeed, the recent popularity in DTI analyses has been promising; however, each of the 
DTI techniques (i.e., VBM, tractography, TBSS) have several limitations which have been 
highlighted in the literature. In this study, the only significant association with physical activity 
was noted with white matter volume. Although some trends were noted with diffusion 
parameters in the healthy controls, this result should not be over-interpreted. While white matter 
volume is not as sensitive to the microstructural changes that occur early in the MS disease 
process, associations with white matter volume are less ambiguous than those with the diffusion 
parameters. 
As described in the Methods Section, the SIENAX software was used to estimate 
normalized whole-brain grey matter and white matter volumes (Smith et al., 2002). This method 
defines brain size with respect to skull size, and is normalized to the MNI152 standard template. 
This procedure reduces within-group variability, making cross-sectional comparisons more 
sensitive (Smith et al., 2002). Additionally, the segmentation procedure estimates the partial 
volume effects at all voxels (i.e., to what extent a particular voxel contains more white or grey 
matter in areas of overlap), providing greater accuracy in identifying the different tissue types. 
This method has been validated, and the mean error in segmentation was determined to be 0.4% 
of brain volume, while the mean error in normalized brain volume (including white/grey matter 
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volume) was 1% (Smith et al., 2002). As such, estimates of normalized white matter volume in 
this study are likely reliable and valid. Indeed, it appears as though a direct measure of white 
matter (such as white matter volume) may be more easily interpreted than diffusion parameters, 
which provide an indirect measure of white matter integrity. 
The relation between white matter volume and white matter microstructure (i.e., diffusion 
parameters) remains to be fully described. As mentioned, while a positive association between 
FA and white matter volume has been noted (Kochunov et al., 2007), there is limited research 
that has examined this relation. Notably, Tamnes et al. (2010) observed that there were fewer and 
less significant correlations between white matter volume and diffusion parameters, than 
between white matter volume and cortical thickness. This study further noted that for half of the 
queried regions in the brain, white matter volume and white matter microstructure showed 
unique associations with age (i.e., brain maturation). In other words, these measures are not 
totally overlapping and may reflect different maturational processes in the brain. As such, 
examining both white matter volume and white matter microstructure is warranted. 
Ultimately, while diffusion parameters were sensitive to disease pathology in our sample, 
their association with cognitive outcomes and physical activity were inconsistent, and thus 
difficult to interpret. A moderate association between white matter volume and physical activity 
was noted, highlighting the utility of including more direct measures of white matter in this 
population. In future studies, multiple methods for measuring white matter microstructure should 
be employed, in order to optimize the interpretability of the results. Such methods include other 
diffusion MRI techniques, as well as novel neuroimaging techniques for measuring white matter 
in the brain. 
6.5.5 Complementary MRI techniques for measuring white matter 
It may be of utility to compare diffusion parameters with other measures of myelin 
content in the future, such as myelin water imaging; an in-vivo technique which measures water 
content to identify different tissue types (Mackay & Laule, 2012). This technique has been 
validated in post-mortem studies as accurately identifying myelinated axons in the brain 
(Mackay & Laule, 2012). It has further been identified as an appropriate technique in MS 
research, and is able to distinguish between lesions based on age, as well as differentiate between 
NAWM in healthy controls versus adult MS patients (Laule et al., 2008). The utility of myelin 
water imaging should be investigated in pediatric-onset MS, as it may provide a complementary 
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method to DTI analysis for distinguishing white matter abnormalities in this population. 
Moreover, other diffusion MRI techniques which estimate the microstructural features of 
dendrites and axons, such as neurite orientation dispersion and density imaging (NODDI) should 
be conducted in conjunction with standard DTI analyses. NODDI is a novel technique which 
estimates the orientation and density of neurites, both of which are contributing factors to FA 
(Zhang, Schneider, Wheeler-Kingshott, & Alexander, 2012). As such, this method allows for 
density and orientation to be analyzed individually, and thus provides a more specific marker of 
brain integrity than standard DTI analyses. The combination of various indices of white matter 
integrity should be considered for future research in pediatric-onset MS.  
6.6 Limitations and Future Directions 
Despite the limitations of DTI analyses cited in this discussion, further investigation into 
its utility in pediatric-onset MS is warranted, specifically in terms of TBSS. As mentioned above, 
the use of multiple measures of white matter integrity should be employed in future research 
(i.e., myelin water imaging, NODDI). The combination of such measures of white matter 
microstructure, in addition to standard DTI analysis, may have utility in identifying early signs of 
demyelination, and may be more sensitive to disease pathology. 
This study was further limited by the sample being relatively cognitively intact in 
comparison to previously-studied pediatric-onset MS cohorts. Further research investigating the 
association between white matter abnormalities, cognitive ability, and physical activity are 
warranted in this population. A longitudinal design is needed in the future to investigate the long-
term effect of exercise on cognition and white matter. Moreover, collection of the physical 
activity measure was limited in that total minutes for each bout of exercise were not collected. 
Future research should ensure that this information is gathered in order to estimate the amount of 
time that participants are engaging in physical activity. Furthermore, a direct and objective 
measure of physical fitness is warranted in future research. As self-report questionnaires are 
prone to bias, complementing this data with measures such as VO2-max or accelerometry would 
provide a more accurate estimate of fitness.  
6.7 Conclusions 
The proposed study aimed to elucidate the relationship between physical activity, white 
matter integrity, and cognitive efficiency in patients with pediatric-onset MS.  
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This study noted that diffusion parameters were sensitive to disease pathology, as MS 
patients consistently demonstrated lower indices of white matter integrity compared to healthy 
controls. Moreover, the white matter tracts which significantly differed between patients and 
controls also demonstrated strong associations with both T1 and T2 lesion volumes. This study 
did not confirm the hypotheses that diffusion parameters would be associated with cognitive 
outcomes and self-reported strenuous physical activity. It was noted, however, that white matter 
volume was positively associated with the physical activity measure in controls, and trended for 
a positive association in MS. The potential limitations in the sensitivity of TBSS-derived 
diffusion parameters to identify associations with lifestyle and cognitive outcomes was 
discussed. Notably, this study has highlighted the inconsistencies that exist regarding the 
methods employed for conducting DTI analyses to evaluate such associations. Future research 
should aim to use multiple methods for evaluating indices white matter integrity and their 
associations with cognition and physical activity. 
Ultimately, physical activity was noted to be associated with white matter volume. This 
relation, as well as relations with other indices of white matter integrity should continue to be 
investigated in both healthy children and adolescents, as well as in the pediatric-onset MS 
population, as little research exists in this regard. Moreover, longitudinal studies may provide 
insight as to whether physical activity may be associated with greater white matter 
microstructure and contribute to improved cognitive efficiency in pediatric-onset MS patients. 
Demyelination resulting from MS occurs during a critical time when neural networks are 
developing in children. Given the young age of pediatric-onset MS patients, impairment in 
cognition may be due to the abnormal development of major white matter pathways that are 
implicated in cognitive ability. As such, continued investigation of modifiable lifestyle factors 
(such as physical activity) that may moderate disease-related neuroinflammation and cognitive 
decline is warranted.  
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8.0 APPENDIX A: CASE HISTORY FORM 
CASE HISTORY FORM 
This information is confidential and for professional use only. 
Date of MRI and cognitive testing:     Time:  
Subject ID number:  
Name: ___________________________________________________________________ 
Date of Birth: (mm/dd/yy)____________________________________________________ 
Current age:    Sex:  F   M 
Current address: ____________________________________________________ 
Current home phone number: __________________________________________ 
Alternative phone number: ____________________________________________ 
Name of current/past school: ___________________________________________ 
Current or highest grade level completed:  
Mother’s age:____ Mother’s occupation:  
Highest level of school completed by mother:____________________________________ 
Father’s age: ____ Father’s occupation:   
Highest level of school completed by father: ____________________________________ 
Current marital status of parents:    
[ ]  Married/Common-law   [ ]  Divorced [ ]  Separated   [ ]  Widowed 
City and Country of Birth: ______________________________ 
Duration living in birth country:  
If not from Canada, has your family been in Canada 5 years or more?    [ ] yes     [ ] no 
First language spoken: _____________________________ 
Most common language spoken at home:    [ ] English    [ ] Other:_________________ 
 [ ] Combination of English and other language _________________ 
Ancestry:   □ European       □ Asian       □ Middle Eastern     □  Central/South America
□ African □ Caribbean □ Aboriginal □ Unknown
□ Mixed specify):
85 
Race:   □ Caucasion □ Oriental □ Black □ Unknown □ Mixed:___________
Medical History 
If you have MS, when was your last MS related attack? _________________________________ 
Have you received any corticosteroid / IVIg treatment for an attack at least 6 weeks prior to participating in 
this research study?    [ ]  Yes   [ ]  No  
Prescribed Medication at time of testing (including disease-modifying treatment, birth control) 
*used for more than 14 days within 3 months prior to study visit
List Dose Ongoing (Y / N) Duration Reason for use 
Supplements / Vitamins (including allergy, herbal or alternative meds) 
*used for more than 14 days within 3 months prior to study visit
List Dose Ongoing (Y / N) Duration Reason for use 
Were you born full term?  (>37 weeks)   [ ]  Yes   [ ]  No 
Have you ever had a head injury?  [ ]  Yes   [ ]  No   If yes, at what age? ___________________ 
Did you lose consciousness? [ ]  Yes   [ ]  No For how long?  ____________________ 
Do you wear [ ]  Glasses?  [ ]  Contact lenses?    Date of last vision test:  ____________________ 
Reason for corrective lenses? (e.g. for distance, for reading): _______________________ 
Do you drink alcohol?  [  ]  No   [  ]  Yes   
If yes how many drinks per week? _________________________________ 
Do you use any illicit drugs (e.g. cannabis)?   [  ]  No   [  ]  Yes   
If yes, which ones? __________________________ and how often? __________________ 
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Have you ever had or been diagnosed with the following: 
Kidney disease  [ ] no [ ] yes – explain:________________ 
Epilepsy/seizures [ ] no [ ] yes – explain:__________________ 
Febrile convulsion [ ] no [ ] yes – explain:________________ 
Respiratory disease [ ] no [ ] yes – explain:________________ 
Heart disease  [ ] no [ ] yes – explain:________________ 
Hematological problems [ ] no [ ] yes – explain:________________ 
Thyroid disease  [ ] no [ ] yes – explain:__________________ 
Digestive problems [ ] no [ ] yes – explain:________________ 
Diabetes [ ] no [ ] yes – explain:________________ 
Hypertension  [ ] no [ ] yes – explain:________________ 
Circulatory disease [ ] no [ ] yes – explain:________________ 
Cancer  [ ] no [ ] yes – explain:________________ 
Other  [ ] no [ ] yes – explain:________________ 
Behavioural and Mental Health History 
Have you ever been assessed by a psychologist or psychiatrist?   [ ]  No [ ]  Yes 
Reason and date: 
Have you repeated a grade?   [ ]  No [ ]  Yes   
Which grade(s)? ___________  
Are you currently placed in a special education program?   [ ]  No   [ ]  Yes 
Have you been placed in a special education program in the past?   [ ]  No   [ ]  Yes 
Regular classroom?  [ ]  Yes   [ ]  No Modified classroom:  [ ]  Yes   [ ]  No 
Have you ever had or been diagnosed with the following: 
Attention Deficit Disorder  [ ] no [ ] yes – when:________________ 
Attention Deficit/Hyperactivity Disorder [ ] no [ ] yes – when:__________________ 
Anxiety  [ ] no [ ] yes – when:________________ 
Autism Spectrum Disorder [ ] no [ ] yes – when:________________ 
Depression [ ] no [ ] yes – when:________________ 
Any psychiatric disorder  [ ] no [ ] yes – when:________________ 
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Learning Disability (LD) [ ] no [ ] yes – when:________________ 
Language Disorder [ ] no [ ] yes – when:________________ 
Giftedness [ ] no [ ] yes – when:________________ 
Please provide any additional comments you think might be helpful. 
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9.0 APPENDIX B. Supplementary Tables 
Supplementary Table 1. Correlationsa of average diffusion parameters (i.e., entire white matter 
skeleton) and disease characteristics in MS patients (N=23) 
Clinical Characteristic Fractional Anisotropy Axial Diffusivity Radial Diffusivityb
Disease Duration 0.114 -0.448* -0.262
Age of Onset -0.116 0.444* 0.270 
Number of relapses -0.075 -0.253 -0.016
EDSSc Score -0.419* 0.423* 0.443* 




cExpanded Disability Status Scale 
dBased on the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale 
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Entire white matter skeleton 0.098 0.264 0.267 
Corpus Callosum – Genub 0.414* 0.260 0.165 
Corpus Callosum – Body 0.127 0.381 0.193 
Corpus Callosum – Splenium -0.055 0.172 0.269 
Cerebral Peduncle – Rightb -0.085 0.074 0.216 
Cerebral Peduncle – Leftb -0.326 -0.093 -0.145
Internal Capsule – Right Anterior Limb -0.074 0.259 0.155 
Internal Capsule – Right Posterior Limb -0.367* -0.271 -0.116
Internal Capsule – Left Posterior Limb -0.176 -0.163 -0.186
Internal Capsule – Right Retrolenticular Part 0.017 0.057 -0.037
Internal Capsule – Left Retrolenticular Part -0.089 -0.126 0.015 
Corona Radiata – Right Anterior 0.199 0.127 0.170 
Corona Radiata – Left Anterior 0.246 0.345 0.324 
Corona Radiata – Right Superior -0.102 -0.049 0.072 
Corona Radiata – Left Superior -0.063 0.028 0.071 
Corona Radiata – Right Posterior -0.110 0.104 0.053 
Corona Radiata – Left Posterior -0.007 0.061 0.003 
Posterior Thalamic Radiation – Rightb 0.086 0.256 0.378* 
Posterior Thalamic Radiation – Leftb 0.113 0.197 0.344 
Saggital Stratum – Right -0.104 0.045 -0.063
Saggital Stratum – Left 0.007 0.199 0.234 
External Capsule – Right -0.441* -0.298 -0.399*
External Capsule – Left -0.372* -0.202 -0.407*
Fornix – Right -0.111 -0.074 -0.287
Fornix – Left 0.106 0.064 0.077 
Superior Longitudinal Fasciculus – Right -0.084 -0.225 -0.028
Superior Longitudinal Fasciculus – Leftb -0.059 -0.035 0.049 
Axial Diffusivity 
Entire White Matter Skeleton 0.058 -0.165 -0.092
Radial Diffusivity 
Entire White Matter Skeletonb -0.253 -0.282 -0.124
ar-value reported 
*p0.1(trend); **p<0.01
bLog-transformed 
